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ABSTRACT

Herpes simplex virus type-1 (HSV-1) morphogenesis occurs in multiple stages within infected
cells. Initially, the virion capsid assembles within the nucleus and buds through the nuclear membrane
into the cytoplasm. Within the cytoplasm, additional tegument proteins attach to the capsid and the fully
tegumented capsids bud into trans-Golgi network (TGN) derived vesicles. Enveloped virions are
ultimately secreted to extracellular spaces. The process by which the cytoplasmic capsids bud into TGNderived vesicles is not well understood. The prevalent model calls for specific interactions among viral
tegument proteins and membrane proteins and glycoproteins embedded within TGN membranes. To
further investigate the roles of tegument proteins in cytoplasmic virion envelopment, we constructed
deletion mutants of UL11, UL20, both UL11 and UL20, and UL16. UL11 is involved in cytoplasmic
virion envelopment. The ΔUL11 virus exhibits large amounts of unenveloped capsids in the cytoplasm
of infected cells. The phenotype of the double null virus most closely resembled that of the UL20 single
null virus (ΔUL20) in all areas: plaque phenotype, growth kinetics, and ultrastructural characteristics.
To asses whether UL11 has any affect on UL20/gK localization, confocal experiments to determine the
localization of UL11, UL20 and gK were undertaken, revealing that UL11 transport was completely
independent of UL20/gK. Taken together these results indicate that UL11 acts at a step in cytoplasmic
envelopment downstream of UL20, and UL20 is required for proper UL11 function. However, UL11 is
not dependent upon the UL20/gK heterodimer for its transport. To assess the role of UL16 in virion
morphogenesis and egress, the YEbac102ΔUL16 virus was constructed using a recently described RED
markerless recombination system. ΔUL16 showed a large accumulation of intranuclear capsids not seen
in the ΔUL11 virus. This result indicates a two-fold role for UL16 in virion morphogenesis and egress:
1) The nuclear accumulation of capsids seems to suggest that the first and most important role of UL16

xii

is in intranuclear capsid assembly/egress. 2) The cytoplasmic accumulation of capsids suggests that
UL16 also plays a role in cytoplasmic envelopment. These results indicate a possible pathway for the
juxtaposition of cytoplasmic capsids with TGN-derived vesicles for final cytoplasmic envelopment.

xiii

CHAPTER 1
INTRODUCTION

STATEMENT OF PROBLEM AND HYPOTHESIS
Herpes Simplex Viruses are known to be the etiologic agents responsible for many
human diseases including mucocutaneous oral and genital lesions, keratoconjunctivitis, and viral
encephalitis. The herpesvirus life cycle is characterized by a number of distinct events, including
binding of the virus to the cellular membrane and subsequent fusion of the viral and cellular
membranes, transport of virions to the nucleus, replication and transcription of viral DNA,
assembly of capsids and DNA packaging, and acquisition of a final viral envelope and egress
from the cell. Investigating the viral proteins involved these different steps of the herpesvirus
life cycle is an area of intense research interest. While the viral molecular determinants involved
in virus entry are relatively well understood, the mechanisms involved in viral morphogenesis
and egress from infected cells are not well defined.
HSV-1 egress from the nucleus of the infected cell to extra-cellular spaces involves a
number of distinct steps, including primary envelopment by budding into the peri-nuclear space,
de-envelopment into the cytoplasm, cytoplasmic re-envelopment by budding into vesicles
originating from the Trans-Golgi Network (TGN), and translocation of enveloped virions to
extra-cellular spaces. Initially, the virion capsid assembles within the nucleus and the virion
acquires an envelope by budding into the peri-nuclear spaces (Roizman and Sears, 2001).
Subsequently, these enveloped virions fuse with the outer nuclear lamellae leading to the
accumulation of un-enveloped capsids into the cytoplasm. Within the cytoplasm, a number of
additional tegument proteins attach to the capsid and the fully tegumented capsids bud into
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cytoplasmic TGN- derived vesicles. Enveloped virions are ultimately secreted to extra-cellular
spaces through the utilization of cellular vesicular trafficking systems (Browne et al., 1996;
Granzow et al., 2001; Harley, Dasgupta, and Wilson, 2001; Mettenleiter, 2002; Skepper et al.,
2001; Zhu et al., 1995)
The process by which the tegumented cytoplasmic capsids bud into TGN-derived vesicles is not
well-understood. The prevalent model calls for specific interactions among viral tegument proteins and
membrane proteins and glycoproteins embedded within TGN membranes as key factors that drive
cytoplasmic virion envelopment. This model is supported by evidence that specific mutations within
tegument proteins and multiple membrane proteins and glycoproteins inhibit cytoplasmic envelopment
(Mettenleiter, 2004; Mettenleiter, 2006).
The overall hypothesis of the investigations described in this thesis, has been that
there is a sequential and coordinate action of protein-protein interactions among tegument proteins and
cytoplasmic portions of viral glycoproteins that bring about the cytoplasmic envelopment of tegumented
virions. A priori, this hypothesis predicts that different defects exhibited by individual mutations or
deletions of specific tegument proteins and viral glycoproteins that produce virions with partial defects
in cytoplasmic virion morphogenesis can be ordered with respect to each other on the basis of their
phenotypes and replication properties of mutant viruses that carry one or both sets of mutations affecting
one or two different genes.
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STATEMENT OF RESEARCH OBJECTIVES
The goal of this research was to investigate the functional relationship between Herpes
Simplex Virus Type 1 tegument proteins UL11 and UL16 and membrane proteins UL20 and
glycoprotein K (gK) in virion morphogenesis and egress. The specific aims of this research
were:

I.

To determine potential functional relationships between UL11 and UL20/gK.
1.

To delineate UL11 and UL20 functions during the herpesvirus life cycle, UL11null and UL11/UL20-double null viruses were constructed using a BAC
mutagenesis system and extensively characterized by plaque morphology, viral
growth (one-step growth curve), and viral ultra-structural characteristics were
examined suing electron microscopy.

2.

To determine if UL11, a protein that localizes to the TGN during viral infection,
can affect the intracellular transport and TGN localization of UL20 or gK. UL20
and gK are co-dependent on each other for transport. Assesment of intracellular
transport and TGN localization was achieved through the use of epitope tagged
UL11, UL20, or gK were constructed (Foster et al., 2004c). The transport of
these proteins and their effect on each other was determined by confocal
microscopy.

II.

To further investigate the known functinal relationship between the HSV-1 tegument
proteins UL11 and UL16.
1.

UL11 is known to physically interact with UL16 in transient co-transfection
experiments (Loomis, Courtney, and Wills, 2003; Vittone et al., 2005). To further
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investigate the UL11 and UL16 functions during the herpesvirus life cycle, UL16null and UL16/UL11-double null viruses were constructed using a bacterial
artificial chromosome (BAC) mutagenesis system. The phenotypes of these
mutant viruses were extensively characterized by plaque morphology, viral
growth (one-step growth curve), and viral ultra-structural characteristics.

Overall, the results obtained from this research indicate that:
A.

UL20 acts at a step previous to that of UL11 during virion
morphogenesis and egress, and this function is required for UL11 to
function.

B.

Although UL11 is localized to the TGN during viral infections, it has
no effect on the transport of UL20 or gK.

C.

UL16 is not absolutely required for HSV-1 replication in cell culture.
However, UL16-null viruses exhibit less growth and cell to cell spread
than wild type virus. Also, ΔUL16 exhibits a marked defect in nuclear
egress and cytoplasmic envelopment.

The work is presented in individual chapters in a manuscript format having a specific title
for the central theme of each chapter.

Chapter 2:

The UL20 Protein Functions Precede and are Required for UL11 Functions in Herpes
Simplex Virus Type-1 (HSV-1) Cytoplasmic Virion Envelopment
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Chapter 3.

Herpes Simplex Virus Type-1 (HSV-1) UL16 is Required for Efficient Nuclear
Egress and Cytoplasmic Envelopment

LITERATURE REVIEW
History of Herpesviruses
The first description of Herpes Simplex Virus (HSV) can be traced back to the ancient
Greeks. Hippocrates used the term “herpes” to describe lesions that appeared to creep or crawl
along the skin (Wildy, 1973). Descriptions of lesions resembling HSV were also found on a
Sumerian Tablet dated to the 3rd Millennium BC and the Ebers Papyrus, circa 1500 BC (Whitley,
2001). Herodotus is noted as the first to describe an association between the cutaneous lesions
and fever caused by HSV, and Galen recognized that recurrent HSV lesions develop at the same
anatomical location (Whitley, 2001). During the 18th century, Bateman accurately described the
nature of HSV infection as a “restricted group of localized vesicles with a short, self-limiting
course” (Bateman, 1814). The first description of the link between HSV and the genital organs
did not appear until De Morbis Venereis was published by John Astruc, physician for King Louis
XIV, in 1736, after studying the afflictions of French prostitutes (Astruc, 1736).
During the late 19th and early 20th century, human volunteers were often used to test the
transmission of infectious agents, and Vidal showed that HSV was infectious by passing it from
human to another (Vidal, 1873). Gruter, in a switch from human to animal studies, demonstrated
that HSV could be transmitted from rabbit to rabbit, and he is widely credited with the isolation
of HSV by the virology community (Gruter, 1924). In 1939, Burnett and Williams published an
article describing the nature of latency, noting that HSV seems to persist for life and can be
reactivated under stressful conditions to produce visible lesions (Burnet and Williams, 1939).
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The development of tissue culture technology was critical in the isolation of other
members of the human herpesvirus family. Between 1952 and 1956, varicella zoster virus
(VZV), the causative agent of chicken pox, and cytomegalovirus (CMV) were isolated (Craig et
al., 1957; Rowe et al., 1956; Smith, 1956; Weller and Stoddard, 1952). The eventual cultivation
of lymphoblastoid tumor cells and B lymphocytes led to the isolation and study of Epstein-Barr
virus (EBV) (Epstein, Achong, and Barr, 1964). In the 1990s, cultivation of T lymphocytes led
to the isolation of human herpesviruses 6A, 6B, and 7 (Frenkel et al., 1990; Lopez et al., 1988;
Salahuddin et al., 1986). More recently, Representational Differential Analysis (RDA) led to the
discovery of human herpesvirus 8 (Chang et al., 1994).

Taxonomy of Herpesviridae
Identification of the new and apparently related viruses led to a scientific desire for
classification. However, it was not until 1981 that the current herpesvirus classification came
into being. All herpesviruses examined to date are capable of establishing a latent infection in
their natural hosts in a specific set of cells, which varies from one virus to another. Other
biological properties vary, such as the length of the reproductive cycle, and these were used as
the basis of classification, before DNA sequences of the viruses were known. Members of the
family Herpesviridae were initially classified by the Herpesvirus Study Group into three
subfamilies: the Alphaherpesvirinae, the Betaherpesvirinae, and the Gammaherpesvirinae
(Roizman, Bartha, and Biggs, 1973; Roizman et al., 1992; Van Regenmortel et al., 2000). DNA
sequence data has since supported and expanded the platform on which the classification system
rests. Table 1.1 shows the classification of the nine known human herpesviruses (bold type) as
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well as other commonly studied herpesviruses (Roizman et al., 1992; Van Regenmortel et al.,
2000).
Alphaherpesvirinae were classified based on their variable host range, short reproductive
cycle, rapid spread in tissue culture, efficient destruction of infected cells, and the ability to
establish latent infections primarily in sensory ganglia. The subfamily consists of the genera
Simplexvirus, Varicellovirus, Marek’s disease-like virus, and Infectious laryngotracheitis-like
virus (Roizman et al., 1992; Van Regenmortel et al., 2000).
Betaherpesvirinae were characterized by a limited host range, long reproductive cycle,
and slow infection progression in tissue culture. Cells that are infected often become enlarged
(cytomegalia), and the viruses can maintain latency in secretory glands, lymphoreticular cells,
kidneys, and other tissues. The subfamily consists of the genera Cytomegalovirus,
Muromegalovirus, and Roseolovirus (Van Regenmortel et al., 2000).
Gammaherpesvirinae were classified by a limited host range and ability to replicate in
lymphoblastoid cells, with some viruses also causing lytic infection in some types of epithelial
and fibroblastic cells. Viruses are usually specific for either B or T lymphocytes, and latent virus
is frequently demonstrated in lymphoid tissue. The Gammaherpesvirinae subfamily consists of
the genera Lymphocryptovirus (EBV), and Rhadinovirus (Van Regenmortel et al., 2000).
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Table 1.1: Herpesvirus Taxonomy.

Table 1: Members of the family Herpesviridae
Subfamily
Alphaherpesvirinae

Designation

Vernacular Name

Human herpesvirus 1 (HHV-1)
Human herpesvirus 2 (HHV-2)
Human herpesvirus 3 (HHV-3)
Cercopithecine herpesvirus 1 (CeHV-1)
Gallid herpesvirus 1 (GaHV-1)
Gallid herpesvirus 2 (GaHV-2)
Suid herpesvirus 1 (SuHV-1)
Felid herpesvirus 1 (FeHV-1)
Ictalurid herpesvirus 1 (IcHV-1)

Betaherpesvirinae

Gammaherpesvirinae

Herpes simplex virus type 1 (HSV-1)
Herpes simplex virus type 2 (HSV-2)
Varicella-zoster virus (VZV)
Herpesvirus B, Simian Herpesvirus
Infectious laryngotracheitis virus
Marek's disease herpesvirus 2
Pseudorabies virus, Aujesky's disease
Feline herpesvirus 1, Feline rhinotracheitis
herpesvirus
Channel catfish herpesvirus

Human herpesvirus 5 (HHV-5)
Cercopithecine herpesvirus 8 (CeHV-8)
Murid herpesvirus 1 (MuHV-1)
Murid herpesvirus 2 (MuHV-2)
Suid herpesvirus 2 (SuHV-1)
Felid herpesvirus 2 (FeHV-1)
Human herpesvirus 6A (HHV-6A)
Human herpesvirus 6B (HHV-6B)
Human herpesvirus 7 (HHV-7)

Cytomegalovirus (CMV)
Rhesus monkey cytomegalovirus
Mouse cytomegalovirus
Rat cytomegalovirus
Pig cytomegalovirus
Cat cytomegalovirus

Human herpesvirus 4 (HHV-4)
Human herpesvirus 8 (HHV-8)

Epstein-Barr virus (EBV)
Karposi's sarcoma-associated
herpesvirus (KSHV)

Roseolovirus

Clinical Significance of Herpes Simplex Viruses

Epidemiology
Infections caused by HSV occur worldwide in both developed countries and
underdeveloped countries (Black, 1975). There are no known animal carriers for HSV;
therefore, humans remain solely responsible for transmitting virus to other humans. Virus
transmission from an infected to a susceptible individual occurs during close personal contact.
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The frequency of person to person contact appears to be the major mediator of infections
(Whitley, 2001). Due to the fact that HSV infection rarely results in fatality and the nature of
latency, more than half of the world’s population probably has a recurring HSV infection,
enabling the transmission of HSV. Initial HSV infection usually occurs in children less than 5
years old and is most often asymptomatic. The mouth area is the most common location of
infection (Whitley, 2001). Primary infection leads to the shedding of virus from the mouth and
stool for an average of 7 to 10 days (Amir et al., 1997), and neutralizing antibodies appear
between 4 and 7 days after the onset of HSV infection and peak at approximately 3 weeks post
infection (Buddingh et al., 1953).
The primary factors affecting the rate of HSV infection are location, socioeconomic
status, and age. In some studies, by the age of 15, over 95% of children were found to possess
antibodies to HSV (Bader et al., 1978; Black et al., 1974). HSV-1 seroprevalence is much more
common than its counterpart HSV-2 (Fleming et al., 1997; Nahmias, Lee, and BeckmanNahmias, 1990). Because HSV-2 is usually acquired through sexual contact, antibodies to HSV2 are rarely found before the onset of sexual activity. While most genital infections are caused by
HSV-2, there is an ever-increasing proportion attributable to HSV-1 (Corey et al., 1983;
Kalinyak, Fleagle, and Docherty, 1977). Genital HSV-1 infections are usually both less severe
than HSV-2 and less prone to recurrence (Corey et al., 1983; Reeves et al., 1981).

Pathogenesis
Initially, virus must come in contact with a mucosal surface or abraded skin for HSV
infection to be initiated. After primary infection, viral replication at the infected location,
usually oral or genital mucosal tissue, results in the infection of sensory nerve endings; and virus
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is then transported to the dorsal root ganglia (Baringer and Swoveland, 1973; Bastian et al.,
1972). In HSV-1 infection, the trigeminal ganglia becomes colonized and harbors latent virus;
whereas in HSV-2 infection the sacral ganglia is the site of latency (Whitley, 2001). After the
establishment of latency, certain stimuli can cause reactivation to occur, and virus becomes
evident at mucocutaneous sites as vesicles or ulcers. A more severe primary infection can result
in a higher rate of HSV reactivation.
Cellular changes induced by viral infection include enlargement of infected cells and the
appearance of condensed chromatin within the nuclei, followed by degradation of the nuclei.
Cells lose intact plasma membranes and form multinucleated giant cells. In infected dermal
regions, there is an intense inflammatory response, and the intensity decreases substantially with
recurrent disease (Whitley, 2001).

Mucocutaneous Infections
Primary HSV-1 infection can be either totally asymptomatic or can result in a symptoms
in any combination of fever, sore throat, vesicular or ulcerative lesions. However, asymptomatic
infection is generally the rule rather than the exception (Whitley, 2001). The duration of
symptomatic disease in symptomatic children is generally 2 to 3 weeks, with a fever of 101°F to
104°F. The onset of a recurrent HSV-1 infection is generally marked pain, burning, tingling, or
itching, which generally lasts for less than 6 hours, and is followed by vesicle formation within
24 to 48 hours (Spruance and Crumpacker, 1982; Spruance et al., 1984; Spruance et al., 1977).
Usually, 3 to 5 vesicles appear at the border of the lip and last no longer than 48 hours. Pain is
most severe at the outset of vesicle formation and resolves in 4 to 5 days. The frequency of
recurrences varies greatly among individuals, and the factors that influence reactivation are
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poorly defined but may include fever, stress, and exposure to UV light (Segal et al., 1974; Ship,
Miller, and Ram, 1977).
In HSV-2, the most severe clinical symptoms are encountered with primary infection,
characterized by the appearance of macules and papules followed by vesicles, pustules, and
ulcers. The duration of lesions and viral secretion averages about 3 weeks. Men and women
experience both similar and dissimilar symptoms (Corey, 1982; Corey et al., 1983). Preexisting
immunity to HSV-1 can have a beneficial effect in reducing the severity of HSV-2 primary
infections (Allen and Rapp, 1982; Corey et al., 1981; Kaufman et al., 1973). Recurrent HSV-2 is
milder than initial infection and is characterized by the appearance of 3 to 5 vesicles (Adams et
al., 1976). Symptoms usually last 7 to 10 days, and virus is shed for an average of 2 to 5 days.
The biggest problem involving recurrent genital herpes is the frequency of recurrences, which
varies by individual. Recurrences usually occur several times per year; and, whether
symptomatic or asymptomatic, transmission of the infection to sexual partners can occur with
intimate contact (Corey et al., 1983).

Fetal and Neonatal Infections
Neonatal HSV infections occur at a rate of about 1 in 3000 deliveries per year (Nahmias,
Keyserling, and Kerrick, 1983; Nahmias, Keyserling, and Lee, 1989), and infection occurs far
less frequently than genital infections in the adult population. The type of maternal genital
infection at the time of delivery is directly tied to the risk of fetal infection. If the mother has a
primary infection the risk of transmission is approximately 30%, while the risk for recurrent
infection is 3% or less (Brown et al., 1991). The most common route of infection, 75% to 80%,
is intrapartum contact of the fetus with infected maternal secretions (Whitley, 2001). The
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clinical symptoms of neonatal HSV infection are a reflection of the site and extent of viral
replication, with infection being almost always symptomatic and often lethal. Babies with HSV
infection can have disease: localized to the skin, eye, and mouth; encephalitis with or without
skin involvement; or disseminated infection involving multiple organs (Nahmias et al., 1970;
Whitley et al., 1981). The highest mortality rate occurs in babies with disseminated infection. In
addition, frequently occurring HSV-2 cutaneous lesions defined a group at risk for neurological
problems (Whitley et al., 1991).

Infection of an Immunocompromised Host
Patients who are immunocompromised due to immunotherapy, malnutrition or acquired
immunodeficiency syndrome are at risk for severe HSV infections, and these patients may
develop progressive disease involving the respiratory tract, esophagus, or the gastrointestinal
tract (Korsager et al., 1975; Montgomerie et al., 1969). Recurrent HSV infection can occur in
theses patients at multiple sites and healing occurs over an average of 6 weeks (Whitley et al.,
1984). The repeated treatment required for these patients can lead to viral mutants resistant to
antiviral therapy.

Central Nervous System (CNS) Infections
Encephalitis caused by HSV the most common cause of sporadic, fatal encephalitis in
this country (Olson et al., 1967). Some studies estimate a rate as high as 1250 cases per year in
the United States (Whitley, 2001). Encephalitis is caused when then virus spreads past the dorsal
root ganglia, in which latency is usually established, to the CNS. The mechanisms responsible
for this aberrant event in the virus life cycle are unclear. The manifestations of HSV encephalitis
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include primarily focal encephalitis along with fever, altered behavior, and localized
neurological findings. There is usually evidence of a localized temporal lobe disease (Whitley et
al., 1977; Whitley et al., 1981). In untreated patients, mortality exceeds 70% and only 2.5% of
patients return to normal neurological function (Whitley, 2001).

Keratoconjunctivitis
There are 300,000 new cases of HSV eye infection annually, ranking second behind
trauma as the cause of corneal blindness (Binder, 1977). Primary herpetic keratoconjunctivitis
can occur in either a single eye or both eyes, and healing of the cornea can take as long as one
month even with antiviral therapy. Recurrent HSV eye infections occur at a similar rate to HSV1 mucocutaneous infections and most often involve only a single eye. Repeated attacks can last
for weeks or months and progressive disease can result in vision loss (Whitley, 2001).

Prevention and Treatment of HSV Infection
The two methods for control of HSV infections are antiviral therapy and prevention.
Antivirals such as acyclovir and valaciclovir are effective in limiting the extent of HSV infection
and therefore helpful in limiting spread to uninfected individuals. However, post-exposure
antiviral treatment does not prevent lifelong infection of an individual. Prevention of HSV
infection is mainly achieved through avoiding contact with infectious secretions. Vaccination
would be the ideal method of HSV prevention; however, to date no HSV vaccine has been
clinically successful.
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Architecture of the Herpes Virion
Virions of herpes viruses can vary in size from 120nm to 300nm (Roizman and
Furlong, 1974), and consist of: an electron-dense core, an icosadeltahedral capsid around the
core, an amorphous tegument around the capsid, and an outer envelope containing glycoprotein
spikes (Roizman and Furlong, 1974). The variability in the size of herpes virions is due mainly
to variability in the makeup of the tegument and the state of the envelope. A model of the virion
architecture is presented below in Figure 1.1.

The Core
The core of a mature herpes virion contains the viral DNA in the form of a torus that may
appear to be suspended by a proteinaceous spindle to the capsid (Falke, Siegert, and Vogell,
1959; Furlong, Swift, and Roizman, 1972; Nazerian, 1974). The toroidal structure is 50 nm
high, with an inside diameter of 18nm and an outside diameter of 70 nm. The arrangement of the
viral DNA in the torus is not known.

The Capsid
The capsid is approximately 125 nm in diameter in the form of an icosadeltahedron and
features 162 capsomeres, characteristic of all herpesviruses. Capsomeres are either pentons or
hexons, consisting of 5 or 6 VP5 (major capsid protein) monomers, respectively. In the capsid,
the pentons are located on the icosahedral 5-fold vertices, and the hexons make up the faces and
edges. Hexons also contain 6 copies of VP26, attached to the upper edge of VP5 and form a
continuous ring around each hexon (Zhou et al., 1995). A heterotrimeric complex known as the

14

triplex connects the capsomeres; the triplex consists of two copies of VP23 and one copy of
VP19C and acts as a sort of scaffold for the capsid (Spencer et al., 1998).

The Tegument
The tegument is contained between the capsid and the virion envelope and appears
fibrous on negative staining (Morgan et al., 1959; Morgan, Rose, and Mednis, 1968; Wildy and
Watson, 1962). The tegument can be distributed asymmetrically and its thickness can vary
depending on the location of the virion particle within the infected cell. There is less tegument
that is more symmetrically arranged in peri-nuclear virions than in virions in cytoplasmic
vesicles that contain more tegument distributed more asymmetrically (Falke, Siegert, and Vogell,
1959). Tegument proteins are important in various aspects of the virus life cycle and are
believed to have key functions in the early events of infection and virion egress. There is
ordered tegument density around the pentons, suggesting symmetry where the capsid and
tegument interact (Zhou et al., 1999). This density may be due to the VP1-3 protein, an
extremely large 336 kDa protein, thought to be involved in nucleocapsid attachment to the
nuclear pore facilitating DNA release into the nucleoplasm (Batterson, Furlong, and Roizman,
1983; Knipe et al., 1981; Ojala et al., 2000). However, VP1-3 null mutants also accumulate
newly assembled, DNA-filled capsids in the cytoplasm of infected cells, indicating that VP1-3 is
involved in various stages of the virus life cycle (Desai, 2000).

The Envelope
The outer covering of the herpesvirus, the envelope, has a typical trilaminar appearance
(Epstein, 1962) and appears to be made up of altered cellular membranes (Armstrong, Pereira,
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and Andrewes, 1961; Falke, Siegert, and Vogell, 1959; Morgan, Rose, and Mednis, 1968). The
herpesvirus envelope contains numerous glycoprotein extrusions, while the amounts of each
glycoprotein vary. HSV specifies at least 11 different glycoproteins, and the copy number of
each glycoprotein can well exceed 1,000 per virion. Envelope glycoproteins gB, gD, gH, and gL
have been shown to be required for virion entry into susceptible cells.

Organization of the Viral Genome
The viral DNA of herpesviruses is linear and double stranded, but the DNA becomes
circular immediately after release from capsids into the nucleoplasm of the infected cells. The
length of the genome of different herpesviruses varies between 120 to 250 kbp, with the size of
HSV-1 determined to be 152,261 bp (McGeoch et al., 1988). This variability is different than
polymorphism in the genome length of individual viruses, which is due to terminal and internal
repeated sequences that can vary in copy number, leading to variations in genome length of more
than 10 kbp. The total G+C content of herpesviruses varies from 31% to 75%, and this
percentage can vary across the genome (Roizman and Pellett, 2001). HSV-1 and HSV-2 contain
approximately 68% and 69% G+C content, respectively (Becker, Dym, and Sarov, 1968; Kieff,
Bachenheimer, and Roizman, 1971). The sequence arrangement of herpesvirus genomes varies
on the presence and location of reiterated sequences that allow rearrangement to occur. In
Herpes Simplex Virus genomes, the sequences from both termini are repeated in an inverted
orientation and juxtaposed internally. As a result, the genome is divided into two regions,
consisting of the unique long (UL) and unique short (US) regions flanked by inverted repeats
(Figure 1.2). Both components are able to invert relative to the other to form four isomers;
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Figure 1.1: Herpesvirus virion structure. Virions of herpes viruses can vary in size from
120nm to 300nm (Roizman and Furlong, 1974). A virion consists of: an electron-dense core
containing the viral genome, an icosadeltahedral capsid around the core, an amorphous tegument
around the capsid, and an envelope derived from cellular membranes containing glycoprotein
spikes (Roizman and Furlong, 1974). Figure from (Melancon, 2003).
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Figure 1.2. Arrangement of the HSV-1 genome. (A) The top line represents
the prototypic arrangement of the HSV-1 genome with the unique long (UL) and
unique short (US) regions flanked by the terminal repeat (TR) and internal repeat
(IR) regions. (B) The bottom line shows map units of the HSV-1 genome.

and, as predicted, DNA purified from infected cells contains four equivalent populations, which
differ in the relative orientation of the unique long and unique short regions (Roizman and
Pellett, 2001).
The majority of herpesvirus genes contain: a promoter region 50 to 200 bp upstream of a
TATA box, a transcription initiation site 20 to 25 bp downstream of the TATA box, a 5’
untranslated leader sequence of 30 to 300 bp, a single major open reading frame (ORF) with a
translation initiation codon meeting the host requirement for efficient initiation, 10 to 30 bp of 3’
untranslated sequence, and a polyadenylation signal with standard flanking sequences (Roizman
and Pellett, 2001). Some exceptions include genes without a TATA box or genes with a second
in-frame initiator methionine (Chou and Roizman, 1986; Markovitz, Filatov, and Roizman,
1999). Most transcriptional gene products are not spliced, although every herpesvirus expresses
a few spliced genes. Herpesviruses also produce non-coding RNAs, such as the HSV-1 latency
associated transcript (LAT) (Roizman and Pellett, 2001). The different members of the
herpesvirus family encode between 70 and 200 genes, estimated using various methods
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(Roizman and Pellett, 2001). HSV-1 encodes about 90 gene products, with at least 84 of the
transcriptional units encoding proteins (Roizman and Knipe, 2001).

The Herpes Simplex Virus Lifecycle

Virus Attachment and Entry
Herpesvirus entry is a multistep process involving multiple viral glycoproteins acting as
ligands for multiple receptors on the surface of the target cell. Entry is the most critical step in
the HSV life cycle and greatly determines the tropism and pathology of each member of the
herpesvirus family. The wide host range of HSV and narrow host range of EBV can be in part
explained by the ability of each virus to utilize a different array of cell surface binding and entry
receptors. Entry of HSV occurs is three distinct stages: the first step involves virus binding to
the surface of the cell, the second step involves an interaction of gD (HSV-1) with an entry
receptor, and the third step involves fusion of the viral envelope with the plasma membrane of
the cell, releasing the capsid-tegument complex into the cytoplasm of the infected cell (Figure
1.4).

Binding Receptors
Initial contact of herpesviruses with cells usually occurs through binding receptors, in
which engagement of the virus with receptor is reversible and changes in the virion envelope
required for fusion and entry do not occur. Herpes Simplex viruses initial attachment to cells
involves the interaction of glycoprotein C, and glycoprotein B to a lesser extent, with cell surface

19

Herpes Simplex Virus Life Cycle

α
β
γ

Figure 1.3: The Herpes Simplex Virus Life Cycle. The first stage of the herpes virus life cycle
consists of virus entry, capsid transport to the cell nucleus, deposition of viral DNA into the
nucleoplasm, coordinate gene expression and viral DNA replication (black arrows). The second
stage is virion morphogenesis and egress comprised of primary envelopment at the inner nuclear
membrane, de-envelopment at the outer nuclear membrane, final envelopment into cytoplasmic
vesicles and transport to extra-cellular spaces (red arrows). Figure from (Melancon, 2003).
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glycosaminoglycans, usually heparan sulfate (Shieh et al., 1992; WuDunn and Spear, 1989).
Heparan sulfate is synthesized as the glycosaminoglycan component of heparan sulfate
proteoglycans, and it is widely distributed on cell surfaces in mammals. The presence of heparan
sulfate is not essential for virus entry, but it greatly increases the efficiency of virus entry into
cells (Banfield et al., 1995). Similarly, although glycoprotein C confers the greatest efficiency
for virus attachment to cell surfaces, increasing the efficiency of virus binding by approximately
10 fold, it is not essential for either virus entry or replication (Heine et al., 1974).

Entry Receptors
Binding of the HSV glycoprotein D to an entry receptor sets in motion an irreversible
chain of events leading to the fusion of the virion envelope with the plasma membrane of the
target cell. There have been three classes of HSV entry receptors classified to date, indicated
below and shown in Figure 1.5.

Tumor Necrosis Factor (TNF) Receptor Family
HVEM / Herpes Virus Entry Mediator A (HveA) is a member of the TNF receptor family
and is expressed in a variety of different cell types including lymphocytes, other leukocytes,
epithelial cells, and fibroblasts. While HVEM is utilized by herpes simplex viruses as an entry
receptor, the natural ligands for HVEM include LIGHT and lymphotoxin-alpha (Mauri et al.,
1998). LIGHT can function as a second signal for T-cell activation, and the interactions between
LIGHT and HVEM are the focus of active investigations of the regulation of immune responses
(Kwon et al., 2003). HVEM serves as an excellent entry mediator for both HSV-1 and HSV-2.
Certain studies have shown that HSV-1 entry of activated T-cells is principally mediated by
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HSV-1 Viral Entry
gH/gL
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Figure 1.4: Herpes Simplex Virus Entry. The first step of HSV entry is attachment to the
plasma membrane of infected cells through interaction of gC (ligand for binding) with cell
surface heparan sulfate (receptor for binding). The second step is fusion of the viral envelope
with the cell plasma membrane and occurs following attachment of gD (ligand for fusion) to
either HVEM or a nectin (receptor for fusion) on cell surfaces. Fusion requires the presence of
gD and an entry receptor, as well as gB and the gH/gL heterodimer. Figure from (Melancon,
2003).
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HSV-1 Cell-Surface Entry Receptors
Tumor necrosis factor
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Figure 1.5: Herpes Simplex Virus entry receptors. The three classes of cell surface receptors
for HSV entry are: the tumor necrosis factor (TNF) receptor family consisting of HVEM, the
immunoglobulin superfamily consisting of the nectins, and 3-O-sulfated heparin sulfate. Only
viral attachment can occur in the absence of an HSV entry receptor. Figure from (Melancon,
2003).

HVEM, although in variety of other cell types HVEM was shown not to be the primary mediator
of virus entry (Montgomery et al., 1996).

Immunoglobulin Superfamily
The second family of herpes simplex virus entry receptors is part of the immunoglobulin
superfamily and includes several isoforms present in both human and nonhuman cells encoded
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by mRNAs that can vary due to alternative splicing. Members of this family have been shown to
act as intercellular adhesion molecules localized at adhesion junctions, in which the carboxylterminal domains bind to L-afadin, a PDZ-binding protein that anchors the receptors to the
cytoskeleton and adheren junctions. These receptors have been named “nectins” on account of
their cellular function (Takahashi et al., 1999). Nectins are highly conserved among mammalian
species in respect to structure, function, and the ability to mediate HSV entry (Milne et al., 2001;
Shukla et al., 2000). The nectins are expressed in a variety of cell types including epithelial
cells, fibroblasts, and neurons (Takai and Nakanishi, 2003). In addition, the distribution of this
class of receptors in human tissues reflects the susceptibility of cells to infection and probably
accounts for both virus entry and cell-to-cell spread (Roizman and Knipe, 2001).
Nectin-1α (Herpes Virus Entry Mediator C, HveC) and nectin-1β (Herpesvirus
Immunoglobulin-like receptor, HIgR) are two mRNA splicing variants containing a common
ectodomain and are expressed on epithelial, fibroblastic, neural and hematopoietic cells; in
keratinocytes; and in human tissues that are the target of HSV infection including skin, brain,
and spinal ganglia (Cocchi et al., 1998; Geraghty et al., 1998). Nectin-1α and nectin-1β have the
ability to mediate entry of all HSV-1 strains, HSV-2, Pseudorabies virus (PrV) and bovine herpes
virus 1 (BHV-1) (Geraghty et al., 1998).
Nectin-2α (Herpes Virus Entry Mediator B, HveB) and nectin-2δ are also mRNA splice
variants, and they mediate the entry of HSV-2, PrV, and certain viable mutant forms of HSV-1
but not wild-type HSV-1 (Lopez et al., 2000; Warner et al., 1998). Nectin-1 and nectin-2 are
related to nectin-3 and nectin-4, and the poliovirus receptor (Takai and Nakanishi, 2003).
Nectin-3 has been shown to be expressed on J cells, which lack HVEM, nectin-1, and
nectin-2. An HSV-1 mutant, designated HSV-1 (JMP), was able to enter into J cells expressing
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nectin-3, but wild-type HSV-1 was not (Cocchi et al., 2004). HSV-1 (JMP) contains mutations
in glycoprotein K as well as glycoprotein D. The mutations in both gK and gD were shown to be
required for HSV-1 (JMP) entry into J cells (Cocchi et al., 2004).

3-O-sulfated Heparan Sulfate (3-OS HS)
Modification of heparan sulfate by D-glucosaminyl 3-O-sulfotransferase isoforms-3
and/or -5 creates 3-O-sulfated Heparan Sulfate (3-OS HS), generating a gD-binding site that
allows heparan sulfate proteoglycans to function as entry receptors for HSV-1. 3-O-sulfated
heparan sulfates are broadly distributed on human cells and tissue and mediate HSV-1 but not
HSV-2 entry (Shukla et al., 1999).

Other herpesvirus receptors
Only alphaherpesviruses (except VZV) encode members of the gD family.
Betaherpesvirus and gammaherpesviruses rely on other viral proteins to serve as ligands for
cellular receptors. EBV uses gp42, which becomes a member of a gH-gL-gp42 complex, to
serve as a ligand for human leukocyte antigen (HLA) class II molecules on B lymphocytes.
Human CMV encodes glycoprotein O (gO), which is unrelated to gp42 but also forms a complex
with gH-gL (Huber and Compton, 1998). In addition, HHV-6A encodes glycoprotein Q (gQ),
which forms a complex with gH-gL (Mori et al., 2003). However, it is unclear whether or not
gO or gQ are required for entry in CMV or HHV-6A, respectively.
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Virus-to-Cell Fusion
After binding of gD to a HSV-1 virus entry receptor, the last step in virus entry is fusion
of the virion envelope with the plasma membrane of the target cell (Morgan, Rose, and Mednis,
1968). The current belief is that gD (Ligas and Johnson, 1988), gB (Sarmiento, Haffey, and
Spear, 1979), and the gH/gL heterodimer (Forrester et al., 1992) are required for the virus-to-cell
fusion process to occur. Since gD is required for entry receptor binding, it would be logical to
hypothesize that receptor binding triggers a conformational change in gD that translates to a
change in gB and gH/gL, resulting in activation of the HSV-1 membrane fusion machinery. In
some cells types, notably CHO cells that express an entry receptor such as nectin-1 and HeLa
cells, endocytosis and acidification of endosomes are required for efficient virus entry.
Interestingly, it was found that endocytic uptake of HSV virions from the cell surface is rapid
and independent of any known gD receptor. In addition, efficient entry through endocytosis
requires cellular PI 3-kinase activity and the viral glycoproteins gB, gD, and gH/gL (Nicola,
McEvoy, and Straus, 2003; Nicola and Straus, 2004). While these two entry pathways are
spatially distinct, they are still functionally similar in that both require the same set of viral
glycoproteins and a gD entry receptor.
Recent studies involving the HSV-1 fusion machinery indicate that these glycoproteins
act in a sequential manner, with gD being involved in Phase I, gH/L in Phase II, and gB in Phase
III (Gianni, Forghieri, and Campadelli-Fiume, 2006; Subramanian and Geraghty, 2007).
Additionally, the crystal structure of HSV-1 gB has been solved, revealing a remarkable
homology to vesicular stomatitis virus (VSV) gB. Along with the similarity to VSV gB, two
domains that indicate HSV-1 gB is intricately involved in virus cell fusion were identified: an
alpha-helical coiled-coil core reminiscent of class I fusion proteins, and two extended beta
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hairpins with hydrophobic tips which are indicative of class II fusion proteins (Heldwein et al.,
2006). Subsequent mutagenesis studies on HSV-1 gB showed that hydrophobic tips of the loops
were vital for proper HSV-1 gB function (Hannah et al., 2007).

Host Protein Shutoff
HSV shuts off the synthesis of cellular protein products in two stages. First, the virus
mediates degradation of the host cell mRNA. Second, there is inhibition of further synthesis and
processing of host mRNA. The virion host shutoff (vhs) function involves structural components
of the virion and does not require de novo protein synthesis after infection (Fenwick and Walker,
1978; Nishioka and Silverstein, 1977; Nishioka and Silverstein, 1978a; Nishioka and Silverstein,
1978b). The isolation of vhs- mutants, which failed to shutoff host cell protein synthesis in HSV1 infected cells, allowed for more detailed study of the viral requirements for host shutoff (Read
and Frenkel, 1983). The UL41 ORF was identified as being responsible for the phenotype in the
vhs- mutants (Fenwick, Morse, and Roizman, 1979; Kwong, Kruper, and Frenkel, 1988; Oroskar
and Read, 1987). The UL41 protein (VHS) is expressed as a γ1 gene (Frink, Anderson, and
Wagner, 1981) and is translated to a 58,000 or 59,500 kDa phosphoprotein (Read, Karr, and
Knight, 1993). In addition, VHS was conclusively shown to be capable of functioning in the
absence of any other viral proteins (Zelus, Stewart, and Ross, 1996). VHS was shown to
function at least in part by inducing endoribonucleolytic cleavage of mRNA in vitro (Elgadi and
Smiley, 1999), and the 5’ end of mRNA is degraded before the 3’ end (Karr and Read, 1999).
VHS appears to form a complex with the transcription factor eIF-4H, and the interaction is
required for RNase activity possibly through targeting to polyribosomes. The VHS and eIF-4H
complex appears to decap cellular mRNA from the 5’ end (Roizman and Knipe, 2001).
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In the context of a vhs- mutant, host protein synthesis is not shut off early in infection and
α and β gene expression is extended in comparison to a wild-type virus. These effects are due to
the fact that VHS accelerates the degradation of both cellular and viral mRNAs. As a result,
during the context of a HSV-1 infection, cellular mRNA levels diminish and as viral mRNA
levels accumulate it is preferentially translated. In this way, VHS may facilitate the transition
from α to β to γ gene expression through shortening the life of the viral mRNAs (Kwong and
Frenkel, 1987; Oroskar and Read, 1987). As a γ1 gene product, VHS accumulates late in
infection, but does not degrade viral mRNA as would be expected. An interaction between
VP16 and VHS at late times blocks the degradation of RNA by VHS (Lam et al., 1996). As a
result, the accumulation of VHS into tegument complexes accomplishes two crucial functions: it
brings VHS into the infected cell to shutoff host protein synthesis, and it regulates the activity of
VHS late in infection when mostly viral mRNA is present.

Virion Transport to the Nucleus
After fusion of the virion envelope with the plasma membrane of the infected cell, the
capsid with its associated tegument complex is deposited into the cytoplasm. Some tegument
proteins disassociate from the complex and remain in the cytoplasm, while others, such as VP16
(αTIF) are transported to the nucleus to effect their functions. The remaining capsid-tegument
complex is then transported along the cell’s microtubule network to a nuclear pore. Studies have
shown that dynein, the microtubule dependent motor, is bound to capsids after entry (Sodeik,
Ebersold, and Helenius, 1997), and these results prompted the theory that incoming capsids bind
to microtubules and utilize the cell’s dynein motor to transport them to nuclear pores. Other
experiments have shown that microtubules in proximity to the plasma membrane become
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disrupted after entry, suggesting that the presence of the capsid-tegument complex may destroy
normal cellular microtubule interactions (Ward et al., 1998). After intracytoplasmic transport to
the nucleus, capsids accumulate at the nuclear envelope and become associated with nuclear pore
complexes. Experiments have shown that the VP1/2 gene is required for DNA release at the
nuclear pore (Batterson, Furlong, and Roizman, 1983; Knipe, Ruyechan, and Roizman, 1979),
and antibodies to nuclear pore transport components block capsid binding (Ojala et al., 2000). It
is believed that binding to the nuclear pore complex produces a structural change in the HSV
capsid, resulting in viral DNA release into the nucleus and an empty capsid docked at the nuclear
pore.

Coordinate Gene Expression
During the course of an HSV infection, there are more than 80 gene products expressed
from the viral genome in a highly regulated cascade fashion (Figure 1.6) in a number of
coordinately expressed groups (Honess and Roizman, 1974). Transcription of viral DNA takes
place in the nucleus, and the host RNA polymerase II is responsible for the transcription of all
viral genes during infection (Alwine, Steinhart, and Hill, 1974; Costanzo et al., 1977). There are
several viral genes that play an important role in the regulation of gene expression at different
times post-infection.
HSV encodes a function responsible for transactivation of α genes immediately after
infection (Post, Mackem, and Roizman, 1981), and this was termed the α gene transactivating
factor (α-TIF). α-TIF was shown to be a component of the tegument capable of inducing the α
genes, which contain the “TAATGArATT” promoter response element, which binds Oct-1.
VP16 was identified as the viral protein responsible for the α-TIF function (Campbell,
29

Palfreyman, and Preston, 1984). After entry, VP16 is released from its interaction with VHS and
the tegument complex. VP16 then binds to a cellular protein called the host cell factor (HCF) or
C1 (Katan et al., 1990; Kristie and Sharp, 1990), and HCF carries VP16 into the nucleus, at
which time the VP16-HCF complex binds to Oct-1 that is bound to viral DNA. This event forms
the activator complex that is responsible for transactivation of α genes (La Boissiere, Hughes,
and O'Hare, 1999). In addition to the Oct-1 binding sites, the promoters for α genes also contain
binding sites for other cellular transcriptional activators upstream of a TATA box that may
contribute to a basal level of α gene expression in rapidly dividing cells in the absence of VP16
(Roizman and Knipe, 2001). The viral requirement for VP16 may be different in resting cells,
such as neuronal cells, where cellular transcription factors are not available. After being
deposited into the nucleus of the infected cell, the HSV-1 viral genome localizes to nuclear
ND10 structures where the transcription of α genes takes place (Maul, Ishov, and Everett, 1996).
At 2 to 4 hours post infection, the viral α genes are expressed at peak levels. There are six viral
α genes: ICP0, ICP4, ICP22, ICP27, ICP47, and US1.5. Five of the six α genes stimulate viral β
gene expression in at least some cell types. In particular, ICP4 is required for all post-α gene
expression (Clements, Watson, and Wilkie, 1977; Dixon and Schaffer, 1980), and its effect is
exerted at the transcriptional level (Godowski and Knipe, 1986). However, the mechanism by
which ICP4 exerts its transcriptional control over β gene expression is unclear. ICP4 is also
responsible for down regulation of α gene products including itself and ICP0, and the “pre α”
gene products ORF P and ORF O. In this case, specific consensus binding sites appear to be
responsible for ICP4 mediated transcriptional regulation (Faber and Wilcox, 1986; Gelman and
Silverstein, 1987; Kristie and Roizman, 1984; Kristie and Roizman, 1986; Muller, 1987). In
addition, ICP4 has different isoforms dependent on different post translational modifications, and
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it is possible that the different functions may be somewhat dependent on the specific isoform
present at different times during the course of the infection. ICP0 promotes viral infection and
gene expression, especially at a low multiplicity of infection (MOI) where its absence leads to a
virus yield that is 100 fold less than a wild type virus (Sinclair et al., 1994; Stow and Stow,
1986). ICP0 is a nonspecific transactivator that induces the expression of the HSV α, β, and γ
genes. Because ICP0 does not bind DNA directly, it appears to act indirectly in modulation of
transcription (Everett, Orr, and Elliott, 1991).
The HSV-1 β genes are produced at peak levels between 4 and 8 hours post infection.
Expression of the viral β genes requires the presence of functional ICP4, but is not dependent on
viral DNA synthesis. β gene products include proteins involved in viral DNA replication and
nucleotide metabolism. These viral proteins promote viral DNA replication, which results in
expression of the γ class of genes. The β genes can be divided into two general groups: β1 genes,
which are expressed shortly after the synthesis of α proteins; and β2 genes, which are expressed
with more of a delay after a gene expression (Roizman and Knipe, 2001). β1 genes are
exemplified by the single-stranded DNA binding protein, ICP8, and the large subunit of
ribonucleotide reductase, ICP6. β2 genes are exemplified by the viral thymidine kinase encoded
by UL23. Some β2 genes require ICP27 for expression, and this dependence may correlate with
the later expression of these genes (Roizman and Knipe, 2001). The HSV-1 γ (late) genes are
produced at peak levels only after viral DNA replication has started, and require ICP4, ICP27
and ICP8 for efficient levels of transcription. The transition from β to γ gene expression is also
marked by a change in the nuclear localization of transcription from sites near ND10 domains to
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Figure 1.6: Coordinate gene expression in Herpes Simplex Virus. 1) α-TIF, a γ gene present
in the tegument, activates initial transcription of the α genes. 2) Autoregulation of gene
expression. 3) Activation of β gene expression. 4) Activation of γ gene expression by α and β
genes, release of repression of γ genes, and replication of the viral genome. 5) γ genes turn off α
and β genes late in infection (Roizman and Knipe, 2001).
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replication compartments as evidenced by the localization of ICP4, RNA polymerase II, and
ICP22 (Knipe et al., 1987; Leopardi et al., 1997; Rice et al., 1994). γ gene products include
structural proteins, glycoproteins, and tegument components required to prepare newly infected
cells for an efficient infection. The γ genes have been subdivided into two groups based on
timing of expression and their dependence on viral DNA replication: γ1 (leaky-late) genes,
which are expressed relatively early in infection and transcription is increased only a few fold
after DNA replication has occurred; and γ2 genes, which do not accumulate in appreciable
amounts until after DNA replication and are not expressed in the presence of inhibitors of viral
DNA synthesis (Wagner, 1985). Typical γ1 genes include the major capsid protein ICP5, gB, gD,
and ICP34.5, whereas typical γ2 genes include gC, UL41 (VHS), UL36, UL38, UL20, and gK.

Viral DNA Replication
After the β genes have been expressed and translated, there are several proteins that are
localized to the nucleus where they assemble on the parental viral DNA in punctuate “prereplicative sites” located near nuclear ND10 structures (Ishov and Maul, 1996; Uprichard and
Knipe, 1996). Initially, viral DNA replication initiates on the circular viral DNA, creating a
“theta” structure, which as replication progresses transitions to a rolling circle mechanism of
replication producing head-to-tail concatemers of viral DNA (Jacob, Morse, and Roizman,
1979). At this point, replication takes place in “replication compartments” that consist of
accumulating DNA molecules and replication complexes (Quinlan, Chen, and Knipe, 1984).
There are seven viral proteins absolutely required for viral DNA replication and sufficient
to replicate a viral origin transfected into cells. These are the viral DNA polymerase (UL30)
(Purifoy, Lewis, and Powell, 1977), its accessory protein (UL42) (Conley et al., 1981), an origin33

binding protein (UL9), the single stranded DNA binding protein (ICP8), and the helicaseprimase complex that consists of three proteins: UL5, UL8, and UL52 (Challberg, 1986; Wu et
al., 1988). Host cell factors may also be involved in DNA synthesis, and host enzymes that
include the DNA polymerase α-primase, DNAligase, and topoisomerase II are almost certainly
also required. There are also three origins of replication located on the viral genome: oriS, a
palindromic sequence of 45 bp that is located in c sequences bounding the S component and
present in two copies; and oriL, a palindromic sequence of 144 bp that is located between the
transcriptional units of ICP8 and the DNA polymerase (UL29 and UL30, respectively) (Deb and
Doelberg, 1988; Frenkel et al., 1976; Knopf, 1986; Locker, Frenkel, and Halliburton, 1982;
Lockshon and Galloway, 1986; Mocarski and Roizman, 1982; Stow, 1982; Vlazny, Kwong, and
Frenkel, 1982; Weller et al., 1985). The reason for the presence of three origins of replication is
not clear, although it may reflect the evolutionary history of the virus. Only one origin of
replication is needed for replication to occur (Igarashi et al., 1993; Polvino-Bodnar, Orberg, and
Schaffer, 1987).
The basic model for the replication of HSV viral DNA proceeds as follows. First, the
parental viral DNA is circularized upon being deposited into the nucleus of the infected cell.
After α and β gene expression, UL9 binds to specific elements in either oriL or oriS and begins
to unwind the viral DNA. UL9 then recruits the ssDNA binding protein ICP8 to the unwound
portion of the viral DNA. At this point, UL9 and ICP8 recruit the remaining five proteins to the
replication forks. The helicase–primase and viral DNA polymerase complexes assemble at each
replication fork and initiate theta form replication. Through an unknown mechanism, replication
switches from theta form to the rolling circle form of replication, and UL9 is not required for
rolling circle replication because it is not origin dependent. The rolling circle replication forms
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long head-to-tail concatamers of viral DNA, which become cleaved into individual units during
packaging of viral DNA into capsids (Roizman and Knipe, 2001).

Capsid Assembly and Packaging
After DNA replication has started, the γ proteins are transcribed, including the HSV-1
capsid proteins. First, empty shells containing an internal scaffold are assembled, with the
internal scaffold lost upon viral DNA packaging into the capsid. Then the mature capsid is able
to proceed along the viral egress pathway. At least some of the initial stages of capsid assembly
occur in the cytoplasm of the infected cell (Nicholson et al., 1994; Rixon et al., 1996). The
major capsid protein (VP5), the outer tip of hexons (VP26), and a triplex protein (VP23) are not
capable of nuclear localization on their own; however, VP5 can be carried into the nucleus by
VP19C, another capsid triplex protein, or by pre-VP22a, a scaffolding protein. VP23 localizes to
the nucleus only in the presence of VP19C, while VP26 localizes to the nucleus only when it is
expressed with both VP5 and VP19C or pre-VP22a (Nicholson et al., 1994; Rixon et al., 1996).
Electron microscopic studies have shown that final envelopment occurs in the nucleus; and three
types of capsids, called A, B, and C capsids have been identified by sucrose density gradient
ultracentrifugation (Gibson and Roizman, 1972). All three types of capsids are about 120 nm in
diameter with an outer shell composed of hexons and pentons made up of VP5. The individual
capsomeres are linked by triplex structures consisting of VP19C and VP23, the two minor capsid
proteins. Each triplex consists of one molecule of VP19C and two molecules of VP23
(Newcomb et al., 1993). C-capsids are mature capsids that contain packaged viral DNA and can
proceed to become infectious virions by budding through the nuclear membrane into the perinuclear space (Perdue et al., 1976). In contrast, A and B capsids lack viral DNA, but B capsids
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are filled with VP22a and VP21, the cleaved scaffolding proteins, and a viral protease VP24
(Gibson and Roizman, 1972; Newcomb et al., 1993). The internal proteins VP22a, VP21, and
VP24 are removed upon packaging of viral DNA to form C capsids (Davison, Rixon, and
Davison, 1992; Gibson and Roizman, 1972). A capsids do not contain viral DNA or scaffolding
proteins and are believed to be an abortive result of failed attempts at DNA packaging.
In terms of the order of assembly, once in the nucleus, VP5-pre-VP22a complexes come
together as a result of self assembly of pre-VP22a. The triplex proteins VP19C and VP23 are
then added to form a partial capsid. As hexons and pentons are added, the structure assembles
into a round procapsid (Newcomb et al., 1996). At his point, the procapsid undergoes a structural
transformation and becomes polyhedral (Church and Wilson, 1997; Thomsen et al., 1995; Trus et
al., 1996). It is unknown at this time whether the round or polyhedral B capsids are the structure
that viral DNA is packaged (Lee, Irmiere, and Gibson, 1988; Perdue et al., 1974; Trus et al.,
1996). Encapsidation of viral DNA is a process in which unit length monomers of viral DNA are
cleaved from concatamers and packaged into preformed B capsids, as originally shown for
pseudorabies virus (Ladin, Blankenship, and Ben-Porat, 1980; Ladin et al., 1982). Cleavage of
concatamers occurs at specific sites and requires the pac1 and pac2 packaging signals (Deiss,
Chou, and Frenkel, 1986; Smiley, Duncan, and Howes, 1990; Varmuza and Smiley, 1985). The
process of encapsidation of viral DNA into capsids is complex and requires several gene
products, including the UL6, UL15, UL25, UL28, UL32, UL33, UL36 and UL37 gene products,
but the mechanism of viral DNA packaging is not well defined (Roizman and Knipe, 2001).
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Herpesvirus Egress
After encapsidation of genomic DNA, mature nucleocapsids acquire an primary envelope
by budding through the inner nuclear membrane into the peri-nuclear space (Vlazny, Kwong,
and Frenkel, 1982). Two conserved herpesvirus proteins, UL31 and UL34 have recently been
shown to be involved in the budding process. UL34 is C-terminally anchored membrane protein
present in the inner and outer nuclear membrane (Klupp, Granzow, and Mettenleiter, 2000),
while UL31 is a nuclear phosphoprotein also present in the nuclear membrane of infected cells
(Fuchs et al., 2002b; Reynolds et al., 2001). The UL31 protein requires UL34 for proper nuclear
targeting (Fuchs et al., 2002b), whereas the UL34 protein appears to possess an intrinsic nuclear
targeting signal (Klupp, Granzow, and Mettenleiter, 2000). However, the nuclear targeting of
UL34 is increased by the presence of UL31 (Fuchs et al., 2002b; Reynolds et al., 2001).
Analysis of UL31 and UL34 deletion mutants has indicated that the absence of either protein
results in a drastic impairment in primary envelopment with capsids trapped within the nucleus
(Chang et al., 1997; Fuchs et al., 2002b; Klupp, Granzow, and Mettenleiter, 2000; Reynolds et
al., 2001; Roller et al., 2000). In addition, partial dismantling of the nuclear lamina has been
observed after HSV infection and may be required so that intranuclear capsids are able to gain
access to the inner nuclear membrane (Scott and O'Hare, 2001). Multiple lines of evidence
indicate that UL31 and UL34 play a role in dismantling the nuclear lamina in infected cells.
Over expression of the UL31 protein in uninfected cells was sufficient to relocalize lamin A/C
from the nuclear rim into nucleoplasmic aggregates, while over expression of UL34 was
sufficient to relocalize some lamin A/C into the cytoplasm (Reynolds, Liang, and Baines, 2004).
More importantly, both UL31 and UL34 have been shown to directly bind lamin A/C, suggesting
that the UL31 and UL34 proteins modify the conformation of the nuclear lamina in infected
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cells, possibly by direct interaction with lamin A/C. Given that the nuclear lamina potentially
excludes nucleocapsids from envelopment sites at the inner nuclear membrane, the lamina
alteration may reflect a role of the UL31/UL34 protein complex in perturbing the lamina to
promote nucleocapsid egress from the nucleus (Baines 2004). It is unclear whether additional
primary envelope and tegument proteins exist that are required for primary envelopment to take
place. The UL11 protein has been proposed to function in primary envelopment and increases
the efficiency of envelopment at this step (Baines and Roizman, 1992b; MacLean et al., 1992).

Egress from the Peri-nuclear Space: De-Envelopment
The subsequent steps in HSV-1 egress following primary envelopment have been in
dispute for some time. Two models were proposed to explain virion egress. The first
model, sometimes called the “lumenal” pathway (CH72 144), suggests that peri-nuclear virions
retain their primary envelope and integrity as they leave the cell through the secretory pathway
(Campadelli-Fiume et al., 1991; Darlington and Moss, 1968; Johnson and Spear, 1982; Johnson
et al., 2001). In this model, virion glycoproteins are modified in transit to the plasma membrane
and peri-nuclear virions should contain the entire complement of tegument and envelope proteins
present on mature extra-cellular virions. The alternative model proposes that the primary
envelope of peri-nuclear virions fuses with the outer nuclear lamellae, resulting in loss of the
primary envelope and some tegument components and translocation of the capsid into the
cytoplasm of the infected cells (Figure 1.7, step II) (Enquist et al., 1998; Mettenleiter, 2000). In
this “de-envelopment re-envelopment” pathway, final tegumentation and envelopment (reenvelopment) occur in cytoplasmic compartments (Figure 1.7, step III). In addition, in this
model peri-nuclear and intracytoplasmic/extra-cellular virions should differ in composition.
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Figure 1.7: Representation of HSV-1 virion morphogenesis and egress. (I) Mature capsids
budding through the inner nuclear membrane into the peri-nuclear space; (II) De-envelopment of
peri-nuclear virions at the outer nuclear membrane; (III) Re-envelopment of cytoplasmic capsids
by budding into cytoplasmic vesicles; (IV) Final egress to the extra-cellular space. The steps at
which UL20 and gK are thought to function in virion egress are indicated by red arrows. Figure
from (Melancon, 2003).
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There is evidence that supports both the “lumenal” and the alternative “de-envelopment
re-envelopment” pathways. However, the vast majority of recent evidence supports the “deenvelopment re-envelopment” model of HSV-1 virus egress. The first line of evidence
supporting the alternative model is that primary envelope and primary tegument of peri-nuclear
virions clearly differ in ultra-structural appearance from the final envelope and final tegument of
extra-cellular virions when observed by electron microscopy (Gershon et al., 1994; Granzow et
al., 2001). In addition, while UL31 and UL34 localize on nuclear membranes and peri-nuclear
virions, the UL31 and UL34 proteins were not detected in extra-cellular virions (Reynolds et al.,
2002). In further support, the major tegument proteins UL46 and UL49 are present in
intracytoplasmic/extra-cellular virions but absent from peri-nuclear virions (Klupp, Granzow,
and Mettenleiter, 2000; Mettenleiter, 2002). Also, the phospholipid composition on the final
virion envelope differs substantially from the composition of the nuclear membrane, explained
only by a two-step envelopment model of HSV virion egress (van Genderen et al., 1994).
Electron microscopic analysis has also demonstrated the fusion of primary envelopes with the
outer nuclear membrane with many herpesviruses including HSV-1 (Granzow et al., 2001;
Harms et al., 2000). As a result, the two-step “de-envelopment re-envelopment” model of virion
egress is congruent with both biochemical and morphological data and constitutes a unified
model for the morphogenesis of herpesviruses (Mettenleiter, 2002).
The mechanism of virion de-envelopment from the peri-nuclear space is unclear.
Deletion of the major glycoproteins involved in other membrane fusion events does not affect the
de-envelopment process as indicated by multiple studies (Cai et al., 1987; Granzow et al., 2001;
Jayachandra, Baghian, and Kousoulas, 1997; Steven and Spear, 1997). It is possible that these
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glycoproteins function in a redundant manner, and that only deletion of multiple genes encoding
glycoproteins would have an observable effect on virion de-envelopment at the outer nuclear
membrane.

Tegumentation in the Cytoplasm
While the complexity of the herpesvirus capsid is not much different than that of other
icosahedral viral capsids such as the picornavirus capsid, the complexity of the herpesvirus
tegument is drastically increased. At least 15 proteins have been identified that are part of the
HSV-1 tegument. Even more proteins make up the tegument of other herpesviruses such as
VZV or CMV (Gibson, 1996; Spengler et al., 2001). Recent data indicate that tegumentation
follows an intricate pattern of protein-protein interactions that contains significant levels of
redundancy built in, at least as observed in cell culture (Mettenleiter, 2002). The tegument
proteins interact with the capsid on one side and the viral envelope proteins on the other side in
order to link the structural components to the final envelope of the HSV-1 virion and to secure
the integrity of the virus particle (Figure 1.7) (Mettenleiter, 2002). For a long time the
herpesvirus tegument was considered unstructured; however, cryoelectron microscopic analysis
has indicated that at least the innermost portion of the tegument located adjacent to the capsid
exhibits icosahedral symmetry, resulting from the interaction of a large tegument protein,
presumably UL36, with the pentons of the capsid (Zhou et al., 1999). The UL36 gene product
has been shown to interact with the major capsid protein VP5, which forms both the pentons and
hexons (Machtiger et al., 1980; McNabb and Courtney, 1992; Newcomb et al., 1993). So, it
appears that the first layer of tegument around the capsid is structured and composed of UL36.
UL37 has been shown to interact with UL36 in co-immunoprecipitation and yeast two-hybrid
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experiments, and capsids that accumulate in the absence of UL37 contain UL36 (Klupp et al.,
2002). UL36 and UL37 appear to be the only tegument proteins conserved in all herpesvirus
subfamilies, and the absence of the HSV-1 UL36 and UL37 proteins abolishes virus maturation
(Desai et al., 2001; Desai, 2000; Klupp et al., 2001). Unfortunately, the subsequent steps in
capsid tegumentation are still largely undefined. Virion morphogenesis still proceeds in the
absence of several other tegument proteins, including UL13, US3 (Purves et al., 1987), UL41,
UL46, UL47 (Rafield and Knipe, 1984; Roizman and Knipe, 2001), and UL49 (Mettenleiter,
2002). So far the most dramatic effect has been seen upon deletion of UL48 (α-TIF), which is
responsible for transducing α gene promoters and makes up a major part of the virus tegument
(Batterson and Roizman, 1983; Heine et al., 1974). The absence of UL48 may interfere with a
later step in virion assembly, presumably affecting tegumentation and re-envelopment in the
cytoplasm (Mossman et al., 2000). Interestingly, UL48 has been shown to interact with other
tegument components, UL49 and UL41 (VHS) (Smibert et al., 1994). Mutant forms of UL41
that do not bind UL48 do not become incorporated into the virion (Read, Karr, and Knight,
1993). Cross-linking studies have indicated that UL48 may interact with gB, gD, and gH (Zhu
and Courtney, 1994), although these interactions have not been confirmed through more
stringent methods.

Final Envelopment and Egress to Extra-cellular Spaces
Following tegumentation in the cytoplasm, HSV-1 capsids bud into cytoplasmic vesicles
derived from the trans-Golgi Network (TGN) or endosomes, acquiring their final envelope
(Figure 1.7, step III). Although the mechanism of secondary envelopment is not well defined, the
study of mutants that contain deletions of certain glycoproteins has shed light on some
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requirements of the final envelopment event. By far the most dramatic effect on secondary
envelopment and final egress is caused by the deletion of either UL20 or gK, and ultra-structural
study of UL20-null and gK-null infected cells reveals a dramatic accumulation of un-enveloped
and aberrantly enveloped capsids in the cytoplasm of infected cells with a marked absence of
extra-cellular virus. With regard to gK-null and UL20-null virus titers, there is also a
corresponding lack of infectious virus in the supernates of infected cells, with close to wild-type
levels of intracellular virus (Foster et al., 2004b; Jayachandra, Baghian, and Kousoulas, 1997).
The ultra-structural phenotypes of UL20-null and gK-null viruses are covered in more detail in
Chapter III and Chapter IV. Following the final envelopment step, nascent virions must still
egress to extra-cellular spaces. The current belief is that cellular transport machinery is utilized
in this step, although the mechanisms are unclear. It is apparent that the late stages in viral
egress may differ depending on the cell type that is infected. For example, deletion of gE and gI,
which have been shown to interact and form a complex, does not impair productive replication of
HSV-1 (Enquist et al., 1998). However, in polarized epithelial cells, wild-type HSV-1 virions
are sorted predominantly to cell junctions, while gE/gI null virions are non-specifically released
into supernatants (Dingwell and Johnson, 1998). Delivery of virus particles to cell junctions
would be expected to enhance virus spread and enable viruses to avoid host immune defenses.
Deletion of multiple genes encoding envelope glycoproteins has revealed that certain
aspects of final envelopment and egress may feature redundant mechanisms, each of which is
sufficient for function, at least in cell culture. For instance, while neither gE/gI or gM is required
for productive replication in PrV or HSV-1, simultaneous deletion of gE/gI and gM results in
drastic inhibition of plaque formation and replication in PrV (Brack et al., 1999). In addition,
simultaneous deletion of UL11 and gM resulted in similar egress defect in PrV (Kopp et al.,

43

2004). In contrast, simultaneous deletion of gE/gI and gM does not have a major effect in HSV1 (Browne, Bell, and Minson, 2004); however, a triple mutant lacking gD, gE, and gI had a
severe defect in the final envelopment step. The authors proposed that HSV gD and the gE/gI
heterodimeric complex act in a redundant fashion to anchor the virion envelope onto tegumentcoated capsids (Farnsworth, Goldsmith, and Johnson, 2003). In contrast, it is also possible that
deletion of multiple glycoproteins indirectly disrupts the integrity of many different proteinprotein interactions required for the final envelopment step and that the resulting phenotype
results from the compounded effects of an abnormal glycoprotein profile. More study of the
reason for defects in double and triple-null viruses is required before conclusions can be drawn
regarding mechanisms of final envelopment.

Formation of Light (L) Particles
The presence of egressing capsids in the cytoplasm is not required for tegument assembly
and subsequent envelopment to take place. The formation of extra-cellular herpesvirus light (L)
particles that lack capsids, consist of only tegument and envelope, and are formed independent of
normal virus maturation have been thoroughly studied in HSV-1 (McLauchlan and Rixon, 1992;
Rixon, Addison, and McLauchlan, 1992). L particles appear to contain the full complement of
tegument proteins as well as an authentic envelope containing all appropriate glycoproteins.
Studies of PrV have shown that L particle formation occurs in the absence of UL36 and UL37,
which are tegument components that are critical for capsid tegumentation. It is possible that
normal tegumentation may be centered on UL36 and UL37 interactions with the capsid and that
UL49 may be required for proper interactions with viral glycoproteins in the final budding and

44

envelopment steps. In the absence of capsids, tegument assembly could proceed anchored on
UL49, resulting in the formation of L particles (Mettenleiter, 2002).

HSV-1 Glycoproteins and Their Putative Functions

Glycoprotein B (UL27)
The HSV-1 UL27 gene encodes the 904 aa glycoprotein B (gB). gB is highly conserved
across all subfamilies of herpesviruses. HSV-1 gB is homotrimeric (aa) type I membrane
glycoprotein composed of a 696-aa ectodomain that is N-glycosylated at multiple sites
(Claesson-Welsh and Spear, 1986; Claesson-Welsh and Spear, 1987; Highlander et al., 1991;
Laquerre, Person, and Glorioso, 1996; Spear, 1993b; Whitley, 2001), a 69-aa transmembrane
domain, and a 109-aa carboxyl-terminal domain. The cytoplasmic domain of gB is the longest
among HSV-1 glycoproteins, implying a crucial role for this domain in gB-mediated functions.
A variety of evidence indicates that gB plays important roles in membrane fusion phenomena
during virus entry and virus-induced cell fusion: HSV-1 mutant viruses lacking gB are not able
to enter into cells (Cai et al., 1987) due to a post-attachment defect that can be resolved by
polyethylene glycol mediated fusion of viral envelopes with cellular membranes (Cai, Gu, and
Person, 1988); Single amino acid substitutions and truncations of the carboxyl terminus of gB
cause extensive virus-induced cell fusion (Baghian et al., 1993; Bzik et al., 1984; Cai et al.,
1988; Gage, Levine, and Glorioso, 1993); Transient co-expression of gB with gD, gH and gL
causes cell-to-cell fusion, which is substantially increased by carboxyl terminal truncations of gB
(Foster, Melancon, and Kousoulas, 2001; Haan, Lee, and Longnecker, 2001; Klupp, Nixdorf, and
Mettenleiter, 2000; Pertel, 2002). Recent evidence suggests that these glycoproteins act in a

45

sequential manner, with gD being involved in Phase I, gH/L in Phase II, and gB in Phase III
(Gianni, Forghieri, and Campadelli-Fiume, 2006; Subramanian and Geraghty, 2007). The crystal
structure of HSV-1 gB has been recently solved, revealing a remarkable homology to vesicular
stomatitis virus (VSV) gB. In addition to homology with VSV gB, two domains that indicate
HSV-1 gB is intricately involved in virus cell fusion were identified: an alpha-helical coiled-coil
core reminiscent of class I fusion proteins, and two extended beta hairpins with hydrophobic tips
which are indicative of class II fusion proteins (Heldwein et al., 2006). Subsequent mutagenesis
studies on HSV-1 gB showed that hydrophobic tips of the loops were vital for proper HSV-1 gB
function (Hannah et al., 2007).

Glycoprotein C (UL44)
The 1,536 bp HSV-1 UL44 gene encodes for the 511 aa long precursor of glycoprotein C
(gC) (Frink et al., 1983). gC contains a 25 aa signal sequence at the N-terminus, a long 453 aa
extra-cellular domain, a 23 aa transmembrane anchoring domain, and a short 10 aa C-terminal
cytoplasmic tail (Homa et al., 1986). The first contact of virions with the surface of susceptible
cells is through glycosaminoglycans (GAGs). gC can mediate the initial binding of HSV-1 virus
to a cell surface GAG, heparan sulfate (HS). The heparan sulfate binding site of gC has been
localized to the N-terminal 120 aa (Tal-Singer et al., 1995). The aminoglycoside neomycin
interferes with the binding of virus to HS mediated by gC (Herold et al., 1994). Although gC is
dispensable for the infection of cultured cells, its presence can increase the efficiency of virus
binding almost 10-fold, at least for HSV-1. The main function of gC binding to GAGs seems to
be concentration of the virus on cell surfaces, enabling the more stable interaction of gD with an
entry receptor.
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Another important function of gC is its ability to inactivate complement to facilitate
immune evasion by HSV-1. The gC of many herpesviruses has the ability to bind C3b
(Eisenberg et al., 1987; Friedman et al., 1984; Huemer et al., 1993; Huemer et al., 1995). The
presence of gC protects the virus and infected cell from antibody (Ab)-independent complement
neutralization and cell lysis (Lubinski et al., 1999; Lubinski et al., 1998), antibody dependant
complement neutralization (Hook et al., 2006), and is an important virulence factor in vivo
(Isaacs, Kotwal, and Moss, 1992; Kotwal et al., 1990; Sahu et al., 1998). HSV-1 mutant viruses
lacking gC are rapidly inactivated by human complement, resulting in up to a 5000 fold loss of
titer (Friedman et al., 1996). While Ab is not required for neutralization of a gC null virus, the
presence of Ab enhances neutralization (Friedman et al., 1996; Harris et al., 1990).
An unresolved issue regarding gC function is the relationship of gC to virus-induced
syncytia formation. Several spontaneously arising syncytial virus strains were found to be gCdeficient. In particular the MP strain variant MP10311 contains a syncytial mutation in gK and
is gC-deficient (Bartoletti et al., 1985). In general, the syncytial phenotype of these strains was
found to be more effectively expressed in the absence of gC, especially in Hep-2 cells (Bond,
Person, and Warner, 1982; Goodman and Engel, 1991; Manservigi, Spear, and Buchan, 1977;
Pertel and Spear, 1996; Tognon et al., 1984). One possible explanation of the enhancement of
the syncytial phenotype is that in the absence of gC, because extra-cellular virus does not bind to
cell surfaces as rapidly, virus-induced cell fusion acts as the preferential method of cell-to-cell
spread of HSV-1.
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Glycoprotein D (US6)
The 1182 bp long US6 gene specifies a 394 aa precursor to glycoprotein D (gD). gD
consists of a 25 aa signal peptide, a long 315 aa ectodoamin containing three glycosylation sites
(McGeoch et al., 1985; Watson et al., 1982), a 22 aa transmembrane domain, and a 32 aa Cterminal cytoplasmic domain (Minson et al., 1986). The ectodomain of gD has 6 cysteine
residues at positions 66, 106, 118, 127, 189, 202 forming disulfide bonds (Long et al., 1992).
Importantly, gD has been shown to act as the viral ligand for all known HSV-1 entry receptors
(Spear, Eisenberg, and Cohen, 2000). As a result, gD is absolutely required for virus entry and
virus-induced cell-to-cell fusion to occur. As discussed earlier, HSV-1 gD has the ability to bind
HVEM, nectin-1, nectin-2, and other cell surface receptors to mediate virus entry. In addition,
cells that express gD are resistant to HSV infection in a dose-dependent manner due to a
saturation of the corresponding entry receptors (Campadelli-Fiume et al., 1988; Johnson, Burke,
and Gregory, 1990). X-ray structures of HSV-1 gD alone and in complex with HVEM revealed
that a portion of gD assumes an Ig-like fold with unconventional disulfide-bonding patterns
(Carfi et al., 2001). There is an N-terminal extension from the Ig-like fold that forms a hairpin
loop in the complex with HVEM but is disordered in the crystals of gD alone. The contacts in gD
for HVEM have been localized to amino acids 7 to 15 and 24 to 32 within the N-terminal hairpin
(Spear and Longnecker, 2003). Mutagenic analysis of HSV-1 gD revealed that the first 32 amino
acids of the N-terminal extension have a critical role in functional interactions of gD with all the
HSV entry-fusion receptors, except for nectin-1, and that the amino acid sequence within this
region governs whether nectin-2 can be recognized as an entry and fusion receptor (Yoon et al.,
2003; Zago and Spear, 2003).
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Glycoproteins E (US8) and I (US7)
The 1652 bp long US8 gene encodes the 550 aa glycoprotein E (gE) (Lee, Para, and
Spear, 1982), while the 1172 bp long US7 gene encodes 390 aa glycoprotein I (gI) (Longnecker
et al., 1987). HSV, VZV, and PrV express a heterodimer of gE and gI that functions to mediate
cell-to-cell spread in epithelial and neuronal tissues (Balan et al., 1994; Card et al., 1992; Cohen
and Nguyen, 1997; Dingwell et al., 1994; Dingwell and Johnson, 1998; Jacobs et al., 1993;
Johnson and Feenstra, 1987; Johnson et al., 1988; Kimura et al., 1998; Kritas, Pensaert, and
Mettenleiter, 1994; Kudelova et al., 1991; Mettenleiter et al., 1987b; Mulder et al., 1994;
Neidhardt, Schroder, and Kaerner, 1987; Polcicova et al., 2005; Tirabassi and Enquist, 1998;
Tirabassi et al., 1997; Whealy et al., 1993). HSV and PRV gE/gI complexes are required for
efficient spread of viruses between certain cultured epithelial cells, neurons, and other polarized
cells with extensive cell junctions but are not needed for spread between highly transformed,
nonpolarized cells, such as Vero or HeLa cells, which do not form cell junctions (Dingwell et al.,
1994; Dingwell, Doering, and Johnson, 1995; Mettenleiter et al., 1987a; Tirabassi et al., 1997;
Wisner et al., 2000; Zsak et al., 1992). For example, plaques formed by a gE-negative HSV
mutant on monolayers of a keratinocyte cell line included eightfold fewer cells than plaques
produced by wild-type HSV-1, yet there was no difference in cell-to-cell spread in monolayers of
HeLa cells (Wisner et al., 2000). Moreover, PRV and HSV gE/gI complexes are required for
spread within synaptically connected neuronal circuitry in the peripheral and central nervous
systems (Babic et al., 1996; Dingwell, Doering, and Johnson, 1995; Mulder et al., 1994;
Tirabassi and Enquist, 1998; Tirabassi et al., 1997; Whealy et al., 1993). gE and gI are
extensively complexed in virus-infected cells (Johnson and Feenstra, 1987; Johnson et al., 1988),
and it is the gE/gI complex that functions in cell-to-cell spread (Dingwell et al., 1994; Dingwell,
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Doering, and Johnson, 1995; Johnson and Feenstra, 1987; Johnson et al., 1988; Olson and Grose,
1998; Tirabassi et al., 1997; Zuckermann et al., 1988). In contrast to their effects on cell-to-cell
spread, HSV and PRV gE/gI complexes do not appear to be required for entry of cell-free virus,
i.e., virus particles applied to the apical surfaces of cells (Dingwell et al., 1994; Mettenleiter et
al., 1987a). HSV-1 gE/gI localizes specifically to the TGN during early phases of infection but
moves out to cell junctions at intermediate to late times. One mechanism by which gE/gI
facilitates cell-to-cell spread of HSV-1 involves the sorting of newly assembled virions to lateral
cell surfaces and cell junctions. Mutant HSV-1 lacking gE accumulated more extensively in the
cytoplasm, at apical cell surfaces, and in cell culture supernatants than did wild-type HSV-1
particles, which were found predominantly at cell junctions (Alconada et al., 1999; Kimura et al.,
1998).
The gE/gI complex is also known as the HSV Fc Receptor (FcR) because of its high
affinity for the Fc portion of IgG. Through binding of the Fc portion of IgG, the gE/gI complex
contributes to the immune evasion capabilities of HSV-1, reducing the effectiveness of antibodydependent cellular cytotoxicity (ADCC) targeting the virus and infected cells (Eberle et al.,
1995).

Glycoprotein G (US4)
The 716 bp long US4 gene encodes the 238 aa glycoprotein G (gG). During infection,
gG is incorporated into nuclear and cytoplasmic membranes in the cell (Frame, Marsden, and
McGeoch, 1986; Sullivan and Smith, 1987). The relevant function of gG in the herpesvirus life
cycle has been difficult to identify. Mutant HSV-1 lacking US4 showed no discernible
phenotypic abnormalities relative to the wild-type HSV-1 virus in non-polarized cells in culture,
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and the absence of gG resulted in only marginal attenuation of the virus in certain in vivo models
(Atkinson, Barr, and Timbury, 1978). However, at the primary site of infection, HSV-1 is
required to infect the apical surfaces of mucosal epithelial cells. Recombinant viruses lacking
gG were shown to be defective in the gC-dependent infection of the apical surfaces of polarized
epithelial cells in culture and also in infection of the apical surfaces of corneal epithelial cells in
vivo (Tran et al., 2000). It is not known whether the gG function in infection is mediated in a
cooperative manner with gC, whereby gG would assist with gC binding, or in an independent
manner, whereby gG would be necessary in a second step that renders the gC interaction
irreversible.

Glycoproteins H (UL22) and L (UL1)
The 2517 bp UL22 gene encodes the 838 aa glycoprotein H (gH). gH is a type I
membrane glycoprotein containing an 18 aa signal peptide, a long 785 aa ectodomain, a single
21 aa transmembrane hydrophobic domain close to the C-terminus, and a 14 aa C-terminal
cytoplasmic tail. The 675 bp UL1 gene encodes the 224 aa glycoprotein L. gL contains a 25 aa
signal peptide; however, unlike other herpesvirus glycoproteins, gL does not contain a
transmembrane domain. It appears that gL is not an integral membrane protein; rather, its
membrane association and incorporation into virus particles is dependent on its interaction with
gH (Dubin and Jiang, 1995). Infected cell membranes contain a heterodimer of gH and gL
(gH/gL). When gH is expressed in transfected cells in the absence of gL, the resulting gH
polypeptide is neither folded nor processed correctly. The malformed gH remains in the
endoplasmic reticulum and undergoes self-aggregation (Foa-Tomasi et al., 1991; Forrester et al.,
1991; Roberts et al., 1991). Similarly, cells infected with a gL-null virus do not produce virions
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containing gH. When cells are infected with a gH-null virus, gL is neither correctly processed
nor incorporated into the plasma membrane or viral envelope (Hutchinson et al., 1992a; Roop,
Hutchinson, and Johnson, 1993). Due to the lack of a transmembrane region, the gL polypeptide
is secreted into the medium (Dubin and Jiang, 1995). When both UL22 and UL1 are cotransfected into cells, the antigenic conformation of the gH/gL heterodimer is identical to that of
virus infected cells, indicating that no other viral proteins are necessary for heterodimer
formation. The mutual interaction of both glycoproteins is mediated by the N-terminal region of
the first 69 aa of gL after cleavage of the 25 aa signal peptide (Roop, Hutchinson, and Johnson,
1993), while gH interacts through a central region of the its extra-cellular domain. C-terminal
cysteine residues are required for proper gH/gL function; however the N-terminal cysteines,
which are located within the putative gH/gL binding site are not required for gH/gL interaction
or function (Cairns et al., 2005).A properly formed gH/gL heterodimer is required for both virus
entry and virus-induced cell-to-cell fusion. Although viruses lacking gH/gL are unable to enter
cells, they are able to attach to the cell surface. Therefore, the role of gH/gL in virus entry is in
during the virus envelope-plasma membrane fusion event and not required for virion attachment
or receptor binding. An interesting result concerning the mechanism of gH/gL functions was
obtained when using anti-gL mAbs directed to the C-terminal portion of gL. Certain mAbs
inhibited virus-induced cell-to-cell fusion resulting from syncytial mutations but not virus entry,
indicating a fundamentally different mechanism may be at work in the two processes (Novotny,
Parish, and Spear, 1996).
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Glycoprotein J (US5)
The 279 bp US5 gene encodes the 92 aa glycoprotein J (gJ) (Ghiasi et al., 1998). gJ
contains a predicted signal peptide as well as a hydrophobic transmembrane domain. The
current function of gJ is unknown. Deletion viruses that lack the US5 ORF show no phenotypic
deficiencies either in vitro or in vivo (Balan et al., 1994). More specifically, a gJ-null HSV-1
was capable of multiplying from an inoculation site in mice and entering and replicating in the
peripheral and central nervous system (Balan et al., 1994). However, it has been shown that
another gene in the unique long (UL) region of the viral genome, UL27.5, has amino acid
sequences common to US5. UL27.5 was discovered due to the fact that antibodies generated
against the 23 kDa gJ cross reacted with an unknown 43 kDa product (Chang et al., 1998). In
contrast to gJ, UL27.5 accumulates in the cytoplasm of infected cells; nevertheless, it may be
possible that UL27.5 and gJ could function redundantly and an observable change in phenotype
would not be seen unless both US5 and UL27.5 were disrupted.

Glycoprotein K (UL53)
The 1017 bp UL53 gene encodes the 338 aa precursor of glycoprotein K (gK) (Debroy,
Pederson, and Person, 1985; Pertel and Spear, 1996). gK contains a cleavable 30 aa signal
sequence as well as two asparagine residues at positions 48 and 58 that are glycosylated by Nlinked mannose (Hutchinson et al., 1992b; Ramaswamy and Holland, 1992). gK is extremely
hydrophobic and was originally proposed to contain four transmembrane domains, with both the
N-terminus and C-terminus predicted to lie on the lumenal/extra-cellular side of cellular
membranes (Debroy, Pederson, and Person, 1985). In contrast, experiments with in vitro
translated gK in the presence of microsomal membranes predicted gK to contain three
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transmembrane domains, with the C-terminal tail located intracellularly (Debroy, Pederson, and
Person, 1985; Mo and Holland, 1997; Ramaswamy and Holland, 1992). However, recent
experiments by our laboratory utilizing epitope tags inserted into specific regions of gK
confirmed the original prediction for the membrane topology of gK (Foster, Alvarez, and
Kousoulas, 2003).
Original attempts to isolate gK-deficient viruses through substitution of UL53 with the
lacZ gene were unsuccessful and it was determined that gK was essential for HSV replication in
vivo (MacLean et al., 1991). A subsequent attempt at the isolation of a F-strain gK-null virus
was successful, resulting in an insertion-deletion mutation in gK that expressed a fusion protein
containing the N-terminal 112 aa of gK. The aberrant virions were significantly less infectious
and did not reach the extra-cellular space, with a high number of naked capsids and aberrant
virions in the cytoplasm (Hutchinson and Johnson, 1995). Furthermore, cells infected with the F
strain gK-null virus caused cell fusion in 143TK- cells. However, a KOS strain containing a
more precise deletion of the UL53 gene resulted in a slightly different phenotype (Jayachandra,
Baghian, and Kousoulas, 1997). While the egress of virions in the KOS gK-null virus was still
severely impaired relative to a wild-type virus, the KOS gK-null did not cause cell fusion in
143TK- cells. A KOS virus that was constructed to mirror the F strain insertion-deletion resulted
in syncytia formation in 143TK- cells, so the syncytial phenotype of the “gK-null” viruses was
attributed to the expression of the N-terminal 112 aa of gK (Jayachandra, Baghian, and
Kousoulas, 1997). Importantly, a precise insertion-deletion gK mutation recently constructed in
an F-strain BAC was not syncytial and showed a similar egress defect, confirming previous
results (Melancon et al., 2005).
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Studies of gK localization in infected cells had previously shown that gK was exclusively
localized in the peri-nuclear spaces and contained unprocessed carbohydrates added in the rough
endoplasmic reticulum, indicating that gK was not transported to the golgi complex and never
reached the cell surface (Hutchinson, Roop-Beauchamp, and Johnson, 1995). Interestingly,
while spontaneous mutations leading to syncytia formation can arise in UL20 (Baines et al.,
1991; MacLean et al., 1991), UL24 (Jacobson, Martin, and Coen, 1989; Sanders, Wilkie, and
Davison, 1982), UL27 (gB) (Bzik et al., 1984; Pellett et al., 1985), and UL53 (gK) (Bond and
Person, 1984; Debroy, Pederson, and Person, 1985; Pogue-Geile et al., 1984; Ruyechan et al.,
1979), a large majority of syncytial mutations map to the UL53 (gK) gene. The number of
syncytial mutation found in gK would seem to be at odds with data indicating that gK never
reaches the surface of infected cells; however, data obtained in our laboratory utilizing viruses
engineered to contain epitope tags in the putative extra-cellular domains of gK indicates that gK
does indeed reach the surface of infected cells, resolving the paradox of how gK could
potentially function in virus induced cell-to-cell fusion (Foster, Alvarez, and Kousoulas, 2003).
In transiently transfected cells, gK localized in the ER and did not reach the cell surface. It was
originally reported for PrV that gK is not correctly processed in a UL20 deletion mutant, and that
coexpression of gK and UL20 restored gK processing at least partially (Dietz et al., 2000). In
support of these original findings, our laboratory showed that coexpression of gK and UL20 in
transfected cells restored the transport of gK to cell surfaces (Foster, Alvarez, and Kousoulas,
2003). Nevertheless, while coexpression of UL20 also restored the transport of syncytial gK
genes in transfected cells, syncytia formation did not result in these experiments, indicating that
additional viral proteins are needed to activate the membrane fusion potential of gK (Foster,
Alvarez, and Kousoulas, 2003).
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Glycoprotein M (UL10) and Glycoprotein N (UL49.5)
The 1422 bp UL10 gene encodes the 473 aa glycoprotein M (gM), which contains eight
predicted hydrophobic transmembrane regions (Babic et al., 1996; Baines and Roizman, 1993).
gM is a component of the virion envelope and is present in the cytoplasmic membranes of
infected cells (MacLean, Robertson, and Jamieson, 1993). However, recent evidence suggests a
role for gM in nuclear egress (Baines et al., 2007). Viruses deficient in the expression of gM
exhibit a 10 to 20 fold reduction in virus titers in Vero or BHK cells and form slightly smaller
plaques (MacLean et al., 1991; MacLean, Robertson, and Jamieson, 1993). The 276 bp UL49.5
(UL49A) gene encodes a 91 aa integral membrane protein (Baines and Roizman, 1993). The
UL49.5 polypeptide contains a 23 aa cleaved signal peptide and a C-terminal hydrophobic
transmembrane domain (Barnett et al., 1992). There are also potential sites for O-glycosylation,
leading to the naming of UL49.5 as glycoprotein N (gN) in some cases. In PrV, the UL49.5
homolog was found to be O-glycosylated and incorporated into virions as a 14kDa envelope
protein (Jons et al., 1996). However, the UL49.5 gene product showed no evidence of
glycosylation in HSV-1 infected cells, and appeared to be abundantly present in virions, linked to
the tegument by disulfide bonds (Adams et al., 1998). While initial attempts at deletion of
UL49.5 were unsuccessful and indicated the possibility that UL49.5 was required for virus
replication (Barker and Roizman, 1992), a more recent attempt utilizing a more precise deletion
resulted in a UL49.5-deficient virus that showed no phenotypic differences in plaque yield or
morphology and only a marginal two-fold difference in virus yield (Adams et al., 1998).
gM and UL49.5 (gN) are conserved throughout alpha, beta-, and gammaherpesviruses
and have been shown to form a complex in a number of herpesviruses analyzed to date (Jons,
Dijkstra, and Mettenleiter, 1998; Koyano et al., 2003; Lake, Molesworth, and Hutt-Fletcher,
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1998; Mach et al., 2000; Wu, Zhu, and Letchworth, 1998). The PrV gM has been shown to act
as an inhibitor of cell fusion resulting from cotransfection of either the PrV gB, gD and gH/gL or
the F protein of bovine respiratory syncytial virus, indicating a general mechanism of fusion
inhibition by gM (Klupp, Nixdorf, and Mettenleiter, 2000). While no definitive interaction
between has been shown between the HSV-1 gM and UL49.5, an enhancement of function has
been demonstrated when both are present, inasmuch as cotransfection of the HSV-1 gM and
UL49.5 significantly inhibited cell fusion caused by the HSV-1 gB, gD and gH/gL or the
Molony murine leukemia virus envelope protein, while transfection of the HSV-1 gM alone did
not inhibit membrane fusion (Koyano et al., 2003). A requirement of both gM and gN for
inhibition of cell fusion was also shown for HHV-8 (Koyano et al., 2003). At this point in time,
the mechanism by which gM and UL49.5 mediate inhibition of cell-to-cell fusion is unknown.

Characterization of the UL20 Protein

The UL20 ORF
The UL20 open reading frame is situated between the UL19 gene and the recently
confirmed UL20.5 gene in the unique long region of the HSV-1 genome. UL20 is expressed as a
γ1 (late) gene that does not require viral DNA replication for expression (Ward et al., 1994), and
is conserved in the alphaherpesviruses.

Membrane Topology of UL20p
Based on its predicted amino acid sequence, the UL20 protein was suggested to be an
integral membrane protein containing two or three hydrophobic transmembrane domains
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(McGeoch et al., 1988). However, when the hydrophobic and membrane-spanning domains of
UL20p were calculated by using the TMPred and SOSUI computer algorithms (Hirokawa, BoonChieng, and Mitaku, 1998; Hofmann and Stoffel, 1993) and used to derive a predicted membrane
spanning model of UL20p, four hydrophobic regions were predicted, with no predicted signal
peptide. This putative UL20p model features four membrane spanning regions, placing both the
66 amino acid amino terminus and the 14 amino acid carboxyl terminus of UL20p within the
cytoplasm (domains I and V). In addition, a third small 10 amino acid domain is predicted to be
located intracellularly (domain III), while the two other domains are predicted to be located
extracellularly (domains II and IV). Domain II is predicted to contain 7 amino acids, while
domain IV is predicted to contain 32 amino acids. As the largest extra-cellular domain, domain
IV holds the best chance for interactions with the extra-cellular portions of other membrane
proteins. This predicted model of the UL20p membrane topology has been partially confirmed
in our laboratory with FLAG epitope tags located either on the N-terminus of UL20p, shown to
be intracellular, or inside of domain IV, shown to be present on the extra-cellular/lumenal side of
cellular membranes (Foster et al., 2004c).

Interdependence With gK for Transport
Initial reports on the cellular localization of the UL20 protein indicated that it was not
expressed at the cell surface but was present in virions purified from extra-cellular fluid and from
the cytoplasm. The UL20 protein was found to be present in the nuclear membranes, in the Golgi
apparatus, and dispersed in the cytoplasm, but was not detected in the plasma membranes of
infected cells (Ward et al., 1994). In contrast, recent experiments performed by our laboratory
show that independently expressed gK or UL20p failed to be transported from the ER in Vero
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cells. Similarly, infection of Vero cells with either a gK-null or UL20-null virus resulted in ER
entrapment of UL20p or gK, respectively. In contrast, transiently coexpressed gK and UL20p
predominantly localized to the TGN, and TGN-localized gK and UL20p were shown to originate
from internalized gK and UL20p expressed at cell surfaces. In all experiments, UL20p and gK
were seen to colocalize, consistent with the hypothesis that gK and UL20p directly interact and
that this interaction is important for their TGN localization and function in the virus life cycle
(Foster et al., 2004c).

Function of UL20p in the HSV-1 Lifecycle
The original description of the role of UL20p in the virus life cycle was predicated on the
observation that an F-strain UL20-null virus, R7225, had a peri-nuclear block in virus egress,
resulting in a large accumulation of virions between the inner and outer nuclear lamellae as well
as an abnormal level of un-enveloped capsids in the cytoplasm. In addition, the R7225 virus
formed small syncytia on 143TK- cells (Baines et al., 1991). However, at the time it was
unknown that the UL20.5 gene was located adjacent to UL20, and the R7225 virus contains an
aberrantly fused gene consisting of the 5’ half of the UL20.5 ORF and the 3’ half of the UL20
gene. As such, it was unknown whether or not the description of the UL20-null phenotype could
be attributed to the aberrant gene. To resolve the true phenotype of an HSV-1 virus lacking the
UL20 gene, our laboratory constructed an insertion-deletion mutation into the HSV-1 KOS-strain
UL20 gene that consisted of removal of the 5’ region of the UL20 ORF, while maintaining the
integrity of both the UL20.5 gene and the promoter for the major capsid protein, UL19. In
accordance with the R7225 virus, the KOS strain UL20-null virus exhibited a defect in virion
egress; however, the block in virion egress consisted solely of an accumulation of un-enveloped
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capsids in the cytoplasm, and no accumulation of peri-nuclear virions was observed (Foster et
al., 2004b). Furthermore, the KOS UL20-null virus did not form syncytial plaques on 143TKcells. The observable phenotypes of the KOS UL20-null virus were in agreement with the
phenotype described for a PrV virus lacking UL20 (Fuchs et al., 1997), indicating that the
previously described phenotype of the R7225 virus was in all likelihood due to the presence of
the aberrantly fused gene. In addition, we found that the UL20 protein was required for virusinduced cell-to-cell fusion resulting from syncytial mutations in either gB or gK, implying that
UL20 may serve to regulate membrane fusion events in HSV-1 (Foster et al., 2004b). In Chapter
IV, we investigate the domains of UL20 that function in gB and/or gK-induced syncytia
formation as well as in virion egress.

Characterization of the UL11 Protein
The UL11 ORF encodes a 96 amino acid tegument protein, which is N-terminally myristylated
(MacLean, Clark, and McGeoch, 1989) and palmitylated (Loomis et al., 2001). The UL11 protein
localizes to nuclear and TGN-derived apparatus derived membranes in infected cells (Baines et al.,
1995), but only to the TGN-membranes in non-infected cells (Bowzard et al., 2000). UL11 was shown
to specifically interact with the UL16 tegument protein, providing a potential docking mechanism for
tegumented capsids onto TGN-membranes(Loomis, Courtney, and Wills, 2003; Vittone et al., 2005). An
HSV UL11-null mutant obtained by deletion of most of the UL11 coding region accumulated capsids
into the nucleus and un-enveloped capsids in the cytoplasm (Baines and Roizman, 1992b), while a
PRV-null virus with the entire UL11 gene deleted showed accumulation of un-enveloped capsids in the
cytoplasm of infected cells embedded in tegument-like material (Kopp et al., 2003).
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Function of the UL11 Protein in the HSV-1 Lifecycle
Previously, the role of UL11 in HSV-1 virion morphogenesis and egress was described based on
the observations of a UL11-null virus obtained by deleting the majority of the UL11 ORF (176 of 291
bps). This virus (R7219) exhibited a major defect in capsid envelopment via budding through the nuclear
membrane resulting in an unusual accumulation of intra-nuclear capsids as well as a reduced number of
enveloped capsids in the cytoplasm (Baines and Roizman, 1992b).

Characterization of the UL16 Protein
The UL16 ORF encodes a 373 amino acid protein (Nalwanga et al., 1996) that exhibits a late
(γ1) expression profile (Costa et al., 1985) and requires viral DNA synthesis for its replication. UL15 is
a rarity among herpes-virus genes in that it consist of 2 exons and 1 intron that are spliced together
(Baines and Roizman, 1992a). The UL16 ORF is located within this intron on the anti-sense strand, and
is conserved among herpesviruses (Costa et al., 1985; Wing, Lee, and Huang, 1996).

Function of the UL16 Protein in the HSV-1 Life Cycle
Initial studies of the function of UL16 involving a UL16 deletion mutant (R7210) revealed that
UL16 protein was dispensable for HSV-1 replication in cell culture, although the virus did replicate at
titres 3 to 10 fold lower than those of the wild type virus (Baines and Roizman, 1991). To investigate
the possibility that the UL15 intron acted to downregulate UL16 expression by an antisense mechanism,
the growth of viruses as well as UL16 protein production with and without the UL15 intro were
compared, with no differences found. However the UL15 splicing event has been shown to be
dispensable for virus replication (Baines and Roizman, 1992a). These two findings make the
importance of the UL15 intron and splicing events unknown.
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The UL16 protein initially appears in the nuclei of infected cells in discrete sites which also
contain large amounts of capsid proteins (Nalwanga et al., 1996; Ward, Barker, and Roizman, 1996).
These sites, known as assemblons, are believed to be sites at which capsid assembly and/or DNA
cleavage and packaging may occur (Ward, Ogle, and Roizman, 1996). These results suggest a possible
role for UL16 in intra-nuclear capsid assembly (Nalwanga et al., 1996). Later in the virus life-cycle,
UL16 protein becomes associated with peri-nuclear virions and is found as a component of purified
virions (Nalwanga et al., 1996). This finding is similar to that of the human cytomegalovirus UL16
homolog, UL94 (Wing, Lee, and Huang, 1996). Interestingly, this finding is not duplicated in HSV-2
(Oshima et al., 1998).
UL16 has been shown to specifically interact with UL11 (Loomis, Courtney, and Wills, 2003;
Vittone et al., 2005). This interaction is dependant upon the presence of an acidic amino acid cluster
and a di-leucine motif located within the first 50 amino acids of UL11 (Loomis, Courtney, and Wills,
2003). UL11 is associated with TGN-derived vesicles via N-terminal palmitolation and myristylation.
The interaction between UL11 on TGN-membranes and the capsid associated UL16 presents a possible
pathway for the recruitment of cytoplasmic capsids to TGN-derived membranes for final envelopment.
In work presented in Chapter 3, we seek to further elucidate the roles of UL11 and UL16 in virion
morphogenesis and egress.
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CHAPTER 2
THE UL20 PROTEIN FUNCTIONS PRECEDE AND ARE REQUIRED FOR
UL11 FUNCTIONS IN HERPES SIMPLEX VIRUS TYPE-1 (HSV-1)
CYTOPLASMIC VIRION ENVELOPMENT
Introduction
Herpes simplex virus type-1 (HSV-1) morphogenesis occurs in multiple stages within infected
cells. Initially, the virion capsid assembles within the nucleus and the virion acquires an initial envelope
by budding into the perinuclear spaces (Roizman and Sears, 2001). Subsequently, these enveloped
virions fuse with the outer nuclear lamellae leading to the accumulation of unenveloped capsids into the
cytoplasm. Within the cytoplasm, a number of additional tegument proteins attach to the capsid and the
fully tegumented capsids bud into cytoplasmic vesicles, which mostly likely originate from the transGolgi network (TGN). Enveloped virions are ultimately secreted to extracellular spaces through the
utilization of cellular vesicular trafficking systems (Browne et al., 1996; Granzow et al., 2001; Harley,
Dasgupta, and Wilson, 2001; Mettenleiter, 2002; Skepper et al., 2001; Zhu et al., 1995). The process by
which the tegumented cytoplasmic capsids bud into TGN-derived vesicles is not well-understood. The
prevalent model calls for specific interactions among viral tegument proteins and membrane proteins
and glycoproteins embedded within TGN membranes as key factors that drive cytoplasmic virion
envelopment. This model is supported by evidence that specific mutations within tegument proteins and
multiple membrane proteins and glycoproteins inhibit cytoplasmic envelopment (Mettenleiter, 2004;
Mettenleiter, 2006). Apparently, multiple glycoproteins may be concurrently involved in cytoplasmic
virion envelopment. Simultaneous absence of both gM and gE, or gM and the gE cytoplasmic tail result
in inhibition of cytoplasmic envelopment for pseudorabies virus (PRV) (Brack et al., 1999; Brack et al.,
2000); however, deletion of gM or gE does not appear to affect HSV-1 cytoplasmic envelopment. In
contrast, deletion of both HSV-1 gD and gE cause accumulation of capsids into the cytoplasm of
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infected cells presumably due to loss of contacts with tegument proteins (Mettenleiter, 2004;
Mettenleiter, 2006). These results suggest that PRV and HSV-1 cytoplasmic envelopment may rely on
different repertoires of protein-protein interactions to drive cytoplasmic virion envelopment.
Of particular interest to these investigations are the membrane proteins: UL11 (Baines and
Roizman, 1992b; Kopp et al., 2004; Kopp et al., 2003), UL20 (Baines et al., 1991; Foster et al., 2004b;
Fuchs et al., 1997; Melancon, Foster, and Kousoulas, 2004b), and UL53 (gK) (Foster and Kousoulas,
1999; Hutchinson and Johnson, 1995; Jayachandra, Baghian, and Kousoulas, 1997), which are known to
be important determinants of cytoplasmic envelopment for both PRV and HSV-1. The UL11 gene
encodes a 96 amino acid tegument protein, which is N-terminally myristylated (MacLean, Clark, and
McGeoch, 1989) and palmitylated (Loomis et al., 2001). The UL11 protein localizes to nuclear and
TGN-derived apparatus derived membranes in infected cells (Baines et al., 1995), but only to the TGNmembranes in non-infected cells (Bowzard et al., 2000). UL11 was shown to specifically interact with
the UL16 tegument protein, providing a potential docking mechanism for tegumented capsids onto
TGN-membranes(Loomis, Courtney, and Wills, 2003; Vittone et al., 2005). An HSV UL11-null mutant
obtained by deletion of most of the UL11 coding region accumulated capsids into the nucleus and
unenveloped capsids in the cytoplasm (Baines and Roizman, 1992b), while a PRV-null virus with the
entire UL11 gene deleted showed accumulation of unenveloped capsids in the cytoplasm of infected
cells embedded in tegument-like material (Kopp et al., 2003).
The UL20 and UL53 (gK) genes encode multipass transmembrane proteins of 222 and 338
amino acids, respectively, and are conserved in all alphaherpesviruses (Debroy, Pederson, and Person,
1985; MacLean et al., 1991; Ramaswamy and Holland, 1992). UL20p and gK localize to TGN
membranes after endocytosis from cell surfaces (Foster et al., 2004b). UL20p and gK are essential for
cytoplasmic virion morphogenesis, since mutant viruses lacking either gK or UL20p accumulate capsids
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within the cytoplasm that are unable to acquire envelopes by budding into TGN-associated membranes
(Dietz et al., 2000; Foster, Alvarez, and Kousoulas, 2003; Foster et al., 2004b; Fuchs et al., 1997;
Melancon, Foster, and Kousoulas, 2004b). Furthermore, UL20p is essential for virus-induced cell
fusion caused by either gB or gK syncytial mutations, and it is necessary for gK cell-surface expression.
Recently, our laboratory has shown that gK and UL20 interact and that this interaction is essential for
their co-transport and membrane fusion and virion morphogenesis functions (Foster et al., 2004d;
Melancon et al., 2005).
The purpose of the present investigations was two-fold: 1) To revisit the role of UL11 in virion
morphogenesis and egress by constructing a new recombinant UL11-null virus in the HSV-1(F) genetic
background that could be directly compared to our previously constructed gK-null and UL20-null
viruses. 2) To investigate whether UL11 and the gK/UL20 heterodimer functioned synergistically or
independently of each other in the late stages of cytoplasmic virion morphogenesis. The bacterial
artificial chromosome (BAC) cloned HSV-1 (F) viral genome was used to generated UL11-single null
and UL11/UL20-double null viruses. Characterization of replication and ultrastructural characteristics of
these recombinant viruses revealed that UL11 played an important role in cytoplasmic virion
envelopment. Furthermore, although UL11 and UL20 were independently transported and localized at
the TGN, UL20 functions preceded and were required for UL11 functions in cytoplasmic virion
envelopment.

Materials and Methods
Cells, viruses, and plasmids
African green monkey kidney (Vero) cells were obtained from the American Type Culture
Collection (Rockville, Md.). Cells were maintained in Dulbecco’s modified Eagle’s medium (Gibco-
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BRL; Grand Island, N.Y.), supplemented with 10% fetal calf serum and antibiotics. The UL19- and
UL20-complementing cell line G5 was a gift of P. Desai (Johns Hopkins Medical Center) (Desai et al.,
1993). A plasmid encoding UL11-GFP was a gift of J Wills (Loomis, Courtney, and Wills, 2003).
Construction of both a UL20-3xFLAG plasmid and a gK-V5 plasmid was described previously (Foster
et al., 2004d). Cell line Fd20-1 constitutively expressing UL20 was constructed in this laboratory
(Melancon, Foster, and Kousoulas, 2004b).

Construction of HSV-1 mutants with deletions of the UL11, and/or UL20 genes (pYEbac102,
pYEbac102ΔUL11, pYEbac102ΔUL20, and pYEBac102ΔUL11ΔUL20)
Insertion-deletion mutagenesis of pYEbac102 DNA was accomplished in Escherichia coli with
the λ gam recE recT (GET) recombination system (Narayanan et al., 1999; Orford et al., 2000) as
described previously for mutagenesis of the KSHV genome (Luna et al., 2004). Electrocompetent
YEBAC102 Escherichia coli DH10B cells were transformed with plasmid pGETrec, which contains the
genes encoding recE, recT, and bacteriophage λ gam, grown on plates containing chloramphenicol (12.5
μg/ml) and ampicillin (100 μg/ml). Individual colonies were picked and grown overnight in LuriaBertani (LB) medium containing chloramphenicol and ampicillin. The next day, the culture was
inoculated into 250 ml of LB containing chloramphenicol and ampicillin until an optical density at 600
nm of 0.4 was reached. Addition of L-arabinose to a final concentration of 0.2% (wt/vol) and further
incubation for 40 min induced expression of the recE, recT and λ gam genes from plasmid pGETrec.
The cells were then harvested and made electrocompetent.
For the ΔUL11-Kan mutation, a PCR fragment containing a kanamycin resistance (Kan) gene
cassette flanked by ~50 bp of viral sequences on both sides was used for recombination to construct
pYEbacΔUL11, containing the Kan gene cassette within the targeted UL11 genomic region.
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Specifically, the Kan gene cassette was inserted 94 nucleotides downstream of the UL11 ATG codon, to
avoid interruption of the UL12 open reading frame (ORF) that overlaps with the 5’ terminus of the
UL11 gene by 87 nucleotides. The remaining coding sequence of the UL11 gene was deleted up to three
nucleotides past the TAA termination codon. The construction of the ΔUL20-GFP-Zeo mutation was
described previously (Melancon et al., 2005). For the ΔUL11ΔUL20 mutation, a PCR fragment
containing either a kanamycin resistance (Kan) gene cassette or a GFP-Zeocin resistance cassette
flanked by ~50 bp of viral sequences on both sides was used for recombination to construct
pYEbac102ΔUL11ΔUL20. Briefly, 40μl of electrocompetent DH10B cells harboring both pYEbac102
and pGETrec were electroporated with 200 ng of each PCR product to delete the target gene(s) (UL11
or UL20) with standard electroporation parameters (1.8 kV/cm, 200 Ω, and 25 μF). Following
electroporation, cells were grown in 1 ml of LB for 60 min and subsequently streaked onto LB agar
plates containing chloramphenicol (12.5 μg/ml) as well as either kanamycin (50 μg/ml) or zeocin (25
μg/ml). Mutant pYEbac102 DNA containing a deletion in the UL11 or UL20 gene was isolated from
bacterial colonies, and a second round of electroporation was performed to remove plasmid pGETrec.
Following electroporation, cells were grown on agar plates containing chloramphenicol as well as either
kanamycin or zeocin.

Confirmation of the targeted mutations in pYEbac102 DNA
HSV-1 BAC DNAs (pYEbac102, pYEbac102ΔUL11, and pYEbac102ΔUL11ΔUL20 were
purified from 500 ml of BAC cultures with the Qiagen large-construct kit (Qiagen; Valencia, Calif.).
PCR primers were designed that lie outside both UL11 and UL20. A PCR test was performed to verify
that the desired mutations were present. All mutations were sequenced to verify the presence of the
desired mutations in the BACs. To verify that no spurious mutations were introduced into the viral
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genome of the individual BAC mutants during mutagenesis or during the transfection procedure, each
null mutation was complimented by expression vectors containing the appropriate gene or genes. Each
complemented virus was verified to have the plaque phenotype characteristics of the wild-type BAC
YEbac102.

Transfection of HSV-1 BAC DNAs
Transient transfection of cells with BAC DNAs was performed with Lipofectamine 2000
(Invitrogen). VERO cells (pYEbacΔUL11) and Fd20-1 cells (pYEbacΔUL11ΔUL20) were grown to
95% confluency in six-well plates. Cells were transfected with BAC DNA mixed with Lipofectamine
2000 in Opti-MEM medium as recommended by the manufacturer (Invitrogen). After 6 h of incubation
at 37°C, the medium was removed from the transfected cells, cells were washed with phosphate buffered
saline, and subsequent fresh Dulbecco’s modified Eagle’s medium with 10% fetal calf serum was added.
At 72 h post transfection, virus stocks were collected.

One-step growth kinetics of YEbac102 mutants
Analysis of one-step growth kinetics was as described previously (Foster, Alvarez, and
Kousoulas, 2003; Foster, Rybachuk, and Kousoulas, 2001). Briefly, each virus at an MOI of 2 was
adsorbed to approximately 6 x 105 Vero cells at 4°C for 1 h. Thereafter, warm medium was added, and
virus was allowed to penetrate for 2 h at 37°C. Any remaining extra-cellular virus was inactivated by
low-pH treatment (0.1Mglycine, pH 3.0). Cells and supernatants were harvested immediately thereafter
(0 h) or after 4, 8, 12, 18, 24, or 36 h of incubation at 37°C. Virus titers were determined by endpoint
titration of virus stocks on Vero cells for pYEbacΔUL11 or G5 cells for pYEbac102ΔUL11ΔUL20.
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Electron microscopy
Cell monolayers were infected with the indicated virus at an MOI of 3. All cells were prepared
for transmission electron microscopy (TEM) examination 24 h post infection. Infected cells were fixed
in a mixture of 2% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH
7.3. Following treatment with 1% OsO4 and dehydration in an ethanol series, the samples were
embedded in Epon-Araldyte resin and polymerized at 70°C. Thin sections were made on an MTXL
ultratome (RMC Products), stained with 5% uranyl acetate and citrate/nitrate/acetate lead, and observed
with a Zeiss 10 transmission electron microscope as described previously (Foster et al., 2004b;
Melancon, Foster, and Kousoulas, 2004b).

Confocal microscopy
To determine intracellular localization of UL20 and gK in the presence or absence of UL11,
Vero cells were grown on cover slips in 6 well plates to 95% confluency and then transfected with
UL11, UL11 and UL20, UL11 and gK, or UL11, UL20 and gK using Lipofectamine 2000 (Invitrogen)
as recommended by the manufacturer. After 6 h of incubation at 37°C, the medium was removed from
the transfected cells, cells were washed with phosphate buffered saline, and subsequent fresh Dulbecco’s
modified Eagle’s medium with 10% fetal calf serum was added. At 48h post-transfection cells were
washed with TBS and fixed with electron microscopy grade 3% paraformaldehyde (Electron
Microscopy Sciences, Fort Washington, PA) for 15 minutes, washed twice with PBS-50 mM glycine,
and permeabilized with 1.0% Triton X-100. Monolayers were subsequently blocked for 1 h with 7%
normal goat serum and 7% BSA in TBS (TBS-blocking buffer) before incubation for 2h with either antiGFP (Immunology Consultants Laboratory, Newberg, OR ) for detection of UL11, anti-FLAG (Sigma
Chemical) for detection of UL20, anti-V5 (Invitrogen, Carlsbad, CA) for detection of gK, anti-TGN 46
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(Serotec, Raleigh, NC) for detection of the Trans-Golgi network, or a combination of these antibodies
as indicated. Alternatively, to determine the intracellular localization of UL11 and UL20 during an
active virus infection, 143 TK- cells were prepared as described above with the exception that 24 h post
transfection the cells were infected with YEbac102ΔUL11ΔUL20 at an MOI of 2. At 48 h postinfection, the cells were prepared as described above.
To visualize specific fluorescence, secondary antibodies were added to the cells. Briefly, cells
were washed thoroughly and Alexafluor 488, Alexafluor 594, and Alexafluor 647 at a 1:750 dilution
were added and incubated for 1 h. Cells were washed again and mounted on slides. The fluorescence
was then visualized using a Leica TCS SP2 laser scanning confocal microscope (Leica Microsystems,
Exton, PA) fitted with a CS APO 63x Leica objective (1.4 numerical aperture). Individual optical
sections in the z-axis, averaged 6 times, were collected at the indicated zoom in series in the different
channels at 1024 x 1024 pixel resolution as described previously (Foster et al., 2004b; Foster et al.,
2004d; Foster, Rybachuk, and Kousoulas, 2001; Fuchs et al., 2002a). Images were compiled and
rendered in Adobe Photoshop.

Results
Construction of the HSV-1 BACs pYEbac102ΔUL11 and pYEbac102ΔUL11ΔUL20
The complete HSV-1(F) genome has been cloned into a bacterial artificial chromosome (BAC;
pYEbac102) enabling the genetic manipulation of the HSV-1 genome in E. coli. (Tanaka et al., 2003).
Previously, we utilized the BAC-based GET homologous recombination system to construct deletions
within the gB, UL20 and gK genes in E. coli (Melancon et al., 2005). A similar strategy was utilized to
construct a HSV-1 BAC with most of the UL11 ORF deleted. Deletion of the UL11 gene was
accomplished using specific oligonucleotide primers (Table 2.1). Specifically, the UL11 deletion
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encompassed 194 bps of the UL11 open reading frame (ORF), while 97 bps of the 5’ UL11 ORF
remained intact. This deletion was engineered to ensure that the UL12 ORF, which overlaps with the
UL11 ORF by 86 bps, was unaffected (see Materials Methods). A similar deletion of the UL11 gene was
constructed in the pYEbac102ΔUL20 genetic background.
For construction of the ΔUL11-Kan mutation, primers A and B were used for homologous
recombination and positioned to remove a 198 bp region of the UL11 gene upon insertion of the
kanamycin cassette extending from nucleotide 96 of UL11 to 3 bases past the UL11 stop codon (Table
2.1; Fig 2.1). The UL11 deletion was constructed so that it does not disrupt the UL12 ORF, which
overlaps the 5’ end of UL11 by 85 bases (see Materials & Methods). An identical UL11
insertion/deletion was constructed on both the wild type pYEbac102 genetic background as well as on
the pYEbac102 ΔUL20 genetic background. A similar methodology was previously used to construct a
recombinant virus carrying a deletion of the UL20 gene after insertion of a GFP-Zeocin gene cassette
(ΔUL20-GFPZeo)(Foster et al., 2004b). This construction deleted a 353 bp region of the UL20 gene
extending from the UL20 ATG to the HpaI site located within the UL20 ORF (Table 2.1; Fig.2. 1).
Each pYEbac102 mutant construct contains one or more of the insertion-deletion mutations mentioned
above: pYEbac102ΔUL11 contains the ΔUL11-Kan mutation; pYEbacΔUL20 contains the ΔUL20GFPZeo mutation; and pYEbac102ΔUL11ΔUL20 contains both the ΔUL11-Kan and the ΔUL20GFPZeo mutations (Fig. 2.1).

PCR-based confirmation of the pYEbac102ΔUL11 and pYEbac102ΔUL11ΔUL20 genotypes
The YEbac102-based genomic constructs were tested for the presence of the engineered insertiondeletion mutations via diagnostic PCR. Primers a and b (Table 2.1; Fig. 2.1), located outside and
bracketing the UL11 gene, amplified the predicted 794 bp UL11 DNA fragments from pYEbac102 and
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Table 2.1: Primer designation. Oligonucleotide primers used for GET recombination. HSV-1 homologous
regions are denoted by uppercase letters, lowercase letters signify sequences which bind to the marker gene.

pYEbac102ΔUL20 (Fig. 2.2; lanes 1, 2). Primers c and d (Table 1; Fig 1), located outside and
bracketing the UL20 gene, amplified the predicted 909 bp UL20 DNA fragments from pYEbac102 and
pYEbac102ΔUL11 (Fig. 2.2; lanes 5, 7). In contrast, diagnostic PCR against the pYEbac102ΔUL11 and
pYEbac102ΔUL11ΔUL20 DNAs using primers a and b (Table 2.1; Fig 2.1) produced PCR-amplified
DNA fragment of 1608 bp, as predicted due to the insertion of the kanamycin gene cassette (Fig. 2.2;
lanes 3, 4). Primers c and d (Table 2.1; Fig. 2.1) located outside and bracketing the UL20 gene amplified

Figure 2.1: Construction of mutant YEbac102s. Schematic of the strategy for the
construction of pYEbac102 mutant BACs. (A) The top line represents the prototypic
arrangement of the HSV-1 genome, with the unique long (UL) and unique short (US) regions
flanked by the terminal repeat (TR) and internal repeat (IR) regions. (B) Shown below are the
expanded genomic regions of the UL11 and UL20 ORFs, the approximate locations of the
genomic sites to which insertion of the marker genes was targeted, and the primers used in
diagnostic PCR to confirm the presence of each mutation. (C) PCR fragments containing the
kanamycin resistance or GFP-Zeocin resistance gene cassette flanked by approximately 50 bp of
viral sequences on both sides were used for targeted GET recombination in E. coli to construct
pYEbac102 mutant BACs with insertion-deletion mutations in the UL11 and/or UL20 ORFs,
respectively. The approximate locations of the primers used in amplification of each PCR
fragment are also shown.
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Figure 2.2: PCR diagnostics. PCR-based diagnostic analysis of pYEbac102ΔUL11 and
pYEbac102ΔUL20 mutants. Oligonucleotide primers a, b (Table 1) were utilized to amplify DNA
fragments containing the Kan inserted gene cassette. (i) Amplification with primers a and b produced the
predicted 1701 size DNA fragment for the pYEbac102ΔUL11 and pYEbac102ΔUL11ΔUL20 genomes
consistent with the insertion of the kan gene cassette, and the predicted 794 bp size fragment for the
pYEbac102 and pYEbac102ΔUL20 controls. (ii) Amplification with primers c and d (Table 1) produced
the predicted 2,469 bp size DNA fragment for the pYEbac102ΔUL20 and pYEbac102ΔUL11ΔUL20
consistent with insertion of the GZ gene cassette, and the 999 bp predicted DNA fragment for the
pYEbac102 and pYEbac102ΔUL11ΔUL20 controls.
the predicted 2,469 bp DNA fragment from pYEbac102ΔUL20 and pYEbac102ΔUL11ΔUL20 due to
the insertion of the GFP-Zeocin gene cassette (Fig. 2.2; lanes 6, 8).

Production of infectious virus from pYEbac102-based constructs
To generate virus stocks from the mutant pYEbac102 constructs, transient transfection of individual
BAC DNAs was performed into Vero cells, or the Fd20-1 cell line, which is transformed with the UL20
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gene and was shown to efficiently complement UL20-null viruses (Melancon, Foster, and Kousoulas,
2004b). Specifically, pYEbac102 and pYEbac102ΔUL11 were transfected into Vero cells, while
pYEbac102ΔUL20 and pYEbac102ΔUL11ΔUL20 were transfected into the UL20 complementing
Fd20-1 cells (Melancon, Foster, and Kousoulas, 2004b). For all transfection experiments, virus plaques
became visible 72 hours post transfection, and virus stocks were collected at appropriate points
exhibiting maximum cytopathic effects.

Plaque morphology and replication kinetics of HSV-1 YEbac102 mutants
As we have noted previously (Melancon et al., 2005), construction of mutant HSV-1 viruses using
the YEbac102 plasmid allows for the rapid generation of recombinant viruses carrying desired mutations
without the need for extensive plaque purification, which is normally needed when recombinant viruses
are produced via classical homologous recombination in cell culture. To assess and compare the effect
of the deletion of the UL11 and UL20 genes in the context of the same viral HSV-1(F) genome on cellto-cell spread, the plaque morphologies of the YEbac102, YEbac102ΔUL11, YEbacΔUL20 and
YEbac102ΔUL11ΔUL20 viruses were examined in Vero cells in the presence or absence of
complementation by either the UL11 or UL20 proteins provided in trans via transient expression (Fig.
2.3). Complementation experiments were performed by transfection of UL20, UL11 or both UL20 and
UL11 expression plasmids followed by infection with the ΔUL11, ΔUL20, or ΔUL11ΔUL20 viruses at
24 hours post transfection. As expected, the wild type YEbac102 produced large plaques on all infected
cells (Fig 2.3: A, B). Infection of non-complementing cells with either YEbac102ΔUL20 or
YEbac102ΔUL20ΔUL11 resulted in very small plaques containing on average 1 to 2 cells (Fig 2.3: E,
G), while infection of non-complementing cells with the pYEbac102ΔUL11 virus resulted in plaques,
which were approximately one-third the average size of the wild-type virus (Fig. 2. 3, C).
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Complementation of the YEbac102ΔUL11, YEbac102ΔUL20, or YEbac102ΔUL11/UL20 by UL11,
UL20 or UL20+UL11, respectively, produced viral plaques similar in size to those of the parental wildtype virus (Fig. 2.3: D, F, H). Furthermore, complementation of the YEbacΔUL20ΔUL11 with the UL20
alone produced a viral plaque similar in size to that of the YEbacΔUL11 virus (not shown).
Complementation of the mutant viruses to wild-type plaque phenotypes was observed at a rate of 6070% for all mutant viruses, indicating the absence of any secondary mutations that could account for the
observed mutant phenotypes.
To examine the effect of the various mutations on virus replication, Vero cells were infected at an
MOI of 2 with either the wild-type or each mutant virus. Virus stocks were prepared at 0, 4, 8, 12, 18,
24, and 36 h.p.i. and titrated in triplicate onto complementing cells (Fig. 2.4). The kinetics of both
YEbac102ΔUL20 and YEbac102ΔUL11ΔUL20 were similar to each other and substantially slower than
that of the YEbac102 virus with maximum titers of more than 3-logs reduced in comparison to the
YEbac102 at 36 h.p.i. The replication kinetics of the YEbac102ΔUL11 virus was reduced in comparison
to the YEbac102, with maximum titers reduced by more than one-log at 36 h.p.i.

Ultrastructural characterization of the YEbac102ΔUL11 and YEbac102ΔUL11ΔUL20 mutant
viruses
The ultrastructural phenotypes of the Ybac102ΔUL20, YEbac102ΔUL11 and
YEbac102ΔUL11ΔUL20 viruses relative to the YEbac102 parental virus were investigated utilizing
transmission electron microscopy at 24 h.p.i. As expected, the YEbac102 virus exhibited no apparent
defects in virion egress as exemplified by the presence of fully enveloped virions extracellularly, as well
as the presence of fully enveloped virions intracellularly (Melancon et al., 2005)(not shown). Unlike the
wild-type virus, ultrastructural visualization of YEbac102ΔUL11, YEbac102ΔUL20, and
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Figure 2.3: Plaque morphology of mutant viruses. Plaque phenotypes of UL11-, UL20-, and
UL11/UL20-double null viruses under complementing and non-complementing conditions.
Vero cell monolayers were either mock transfected or transfected with plasmids expressing
UL11, UL20, or both UL11 and UL20. Transfected cells were infected 24 hrs post transfection
with the corresponding viruses, pYEbac102, pYEbac102ΔUL11, pYEbac102ΔUL20 and
pYEbac102ΔUL11ΔUL20. Individual viral plaques were visualized at 24 hrs post-infection by
immunohistochemistry.
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Figure 2.4: Viral replication kinetics. Comparison of the viral replication characteristics of
YEbac102 (●), YEbac102ΔUL20 (■), YEbac102ΔUL11 (▲), and YEbac102ΔUL11ΔUL20 (○)
on Vero cells. One-step growth kinetics of infections virus production was calculated after
infection at an MOI of 2 followed by incubation at 37°C.

YEbac102ΔUL11ΔUL20 infected Vero cells revealed cytoplasmic defects in virion envelopment. The
YEbac102ΔUL11 mutant produced largely unenveloped capsids in the cytoplasm embedded within
morphologically darker stained areas that may be caused by the accumulation of tegument proteins (Fig.
2.5A). This ultrastructural phenotype appeared to be dissimilar to that of a previously constructed HSV1(F)-null virus (Baines and Roizman, 1992b), in as much, there was no noticeable accumulation of
capsids within nuclei of infected cells. In contrast, the YEbac102 UL11 ultrastructural morphology
was similar to that produced by a pseudorabies (PRV) recombinant virus that lacked the UL11
homologous gene, although the tegument-like staining material surrounding the unenveloped capsids did
not appear to be as concentrated as in the PRV case(Kopp et al., 2003). As reported previously
(Melancon et al., 2005), the YEbac102ΔUL20 mutant virus produced unenveloped capsids in the
cytoplasm as well as aberrantly enveloped virions (Fig. 2.5B). Ultrastructural examination of Vero cells
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Figure 2.5: Ultrastructural characterization of mutant viruses. Ultrastructural morphology
of the YEbac102ΔUL11 (a), YEbac102ΔUL20 (b), and YEbac102ΔUL11ΔUL20 (c) viruses. a)
Confluent cell monolayers were infected with the YEbac102ΔUL11 virus at an MOI of 2,
incubated for 24 hrs at 37°C, and prepared for transmission electron microscopy. Panel A: low
magnification of an (c) infected cell. Panels B, C: higher magnifications of cell shown in panel
A. b) Confluent cell monolayers were infected with the YEbac102ΔUL20 at an MOI of 2,
incubated for 24 hrs at 37°C, and prepared for transmission electron microscopy. Panel A: low
magnification of an (c) infected cell. Panels B, C: higher magnifications of cell shown in panel
A. c) Confluent cell monolayers were infected with the YEbac102ΔUL11ΔUL20 virus at an MOI
of 2, incubated for 24 hrs at 37°C, and prepared for transmission electron microscopy. Panel A:
low magnification of an (c) infected cell. Panels B, C: higher magnifications of cell shown in
panel A. Nuclear (N),cytoplasmic (C) and extracellular (E) spaces are marked, as well as a bar
shown the relative magnification scale.
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infected with the YEbac102ΔUL11ΔUL20 double-null virus revealed virion morphogenetic defects that
were quite similar to the UL20-null and different to that of the UL11-null virus (Fig. 2.5C).

UL11 and UL20 are independently transported to the TGN
It has been previously reported that UL11 localizes to the TGN (Loomis et al., 2001). In agreement
with these findings, transient expression of UL11 in Vero cells resulted in localization of the UL11
protein in the TGN (Fig.2. 6). Previously, we showed that gK or UL20 alone remained at the rough
endoplasmic reticulum when expressed alone. However, co-expression of gK and UL20 resulted in the
TGN localization of both proteins strongly suggesting that these two proteins interact and that this
interaction is necessary for the coordinate transport to the TGN (Foster et al., 2004b). To determine
whether either UL20 or gK expression was able to alter the TGN localization of the UL11 protein, the
UL11 gene was transiently expressed in Vero cells concurrently with either the UL20 or gK gene alone
or with both gK and UL20 genes. UL11 localized to the TGN in the presence of either UL20, gK or both
UL20 and gK (Fig. 2.7). Additional experimentation was performed to ascertain whether the presence
or absence of the UL20 or gK could affect the TGN localization of the UL11 protein in the context of
other viral proteins. In these experiments, 143 TK- cells were transfected with either the UL11, UL20, or
both UL11 and UL20 and 24 hours post transfection, cells were infected with the
YEbac102ΔUL11ΔUL20 virus. Again, the UL11 protein localized efficiently to the TGN (Fig. 2.8).

111

Figure 2.6: Confocal microscopy. Digital images of confocal micrographs showing UL11
localization. Vero cell monolayers were transfected with the UL11-GFP expressing plasmid. At
24 hrs post transfection, cells were washed thoroughly, fixed, and stained with the anti-GFP
antibody (A1), or stained with the Golgi specific marker TGN46 (A2) and fluorescence was
visualized by confocal microscopy. Magnification, x63; zoom x2.

112

Figure 2.7: Confocal microscopy. Comparison of UL11 intracellular localization in the
presence or absence of gK/UL20. Vero cells were transfected with a combination of plasmids
expressing UL11-GFP, UL20, and/or gK. At 24 hrs post transfection, cells were washed
thoroughly, fixed, and prepared for confocal microscopy after staining with the appropriate
conditions and antibodies. UL11 was stained with the anti-GFP antibody, UL20 with the antiFLAG antibody and gK with the anti-V5 antibody. (A) UL11+UL20 localization. (B)
UL11+gK localization. (C) UL20+gK localization. (D) UL11+UL20+gK localization.
Magnification, x63; zoom x2.

113

Figure 2.8: Confocal microscopy. Intracellular localization of the UL11 and UL20 proteins in
virus-infected cells. Vero cells were transfected with plasmids expressing UL11-GFP, UL20, or
both. At 24 hrs post-transfection, cells were infected at an MOI of 2 with
YEbac102ΔUL11ΔUL20. At 24 hrs post infection, cells were washed thoroughly, fixed, stained
with appropriate antibodies, and prepared for confocal microscopy. (A) UL11 localization. (B)
UL20 localization. (C) UL11+UL20 localization. Magnification, x63; zoom x2.
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Discussion
HSV-1 cytoplasmic virion envelopment is thought to be mediated by complex interactions
among tegument proteins and viral glycoproteins embedded in the TGN membranes. A number of viral
glycoproteins have been shown to either interact with tegument proteins or otherwise affect cytoplasmic
envelopment. In this manuscript, we examined potential physical and functional relationships between
the UL11 protein and the gK/UL20 heterodimer in cytoplasmic virion envelopment. Specifically, it was
of interest to compare the ultrastructural phenotype of a newly constructed UL11-null virus in the HSV1(F) background with that of the gK-null and UL20-null viruses and to determine whether UL11 and the
gK/UL20 heterodimer functioned in a dependent or independent manner to each other. The salient
features of our results are: 1) The HSV-1 UL11 protein functioned exclusively in cytoplasmic
envelopment as evidenced by the accumulation of cytoplasmic capsids in cells infected with the HSV1(F) UL11-null virus in a manner similar to the previously described PRV UL11-null virus(Kopp et al.,
2003); 2) The UL20-null and UL11-null plaque morphology, as well as their ultrastructural phenotypes
were substantially different; 3) A double UL20/UL11-null virus produced plaques and ultrastructural
morphologies closely resembling those of the UL20-null viral phenotype; 4) The UL11/UL20- double
null virus replicated with replication kinetics similar to that of the UL20-null virus; 5) UL11 and UL20
were transported independently of each other in transient transfection experiments. These results led to
the conclusion that UL20 and UL11 transport and localize at the TGN independently of each other;
however UL20 must function at a virion morphogenetic step occurring prior to and required for UL11
function.
Recently, we constructed and characterized deletion mutants of the gK, UL20, and gB genes
utilizing the HSV-1(F) genome cloned into a bacterial artificial chromosome (BAC) system (Melancon
et al., 2005). The HSV-1 gK-null and UL20-null viruses produced smaller plaques than the original gK-
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null and UL20-null viruses, which were constructed via classical recombination/deletion methodologies
in the HSV-1(KOS) genetic background (Foster et al., 2004b; Jayachandra, Baghian, and Kousoulas,
1997). This apparent very small plaque phenotype could be due to the difference in viral strains.
Alternatively, we favor the hypothesis that the BAC-assisted construction of mutant viruses allowed the
rapid generation of mutant genomes in E. coli substantially lowering the possibility that compensatory
mutations that increase plaque size may be selected after serial passage of the KOS gK or UL20-null
viruses. Appreciably, the very small plaque phenotype of the UL20/gK null viruses exemplify that the
gK/UL20 proteins are essential for virus spread.
To compare the role of UL11 in virion morphogenesis, The YEbac102ΔUL11 (ΔUL11) virus was
produced using our previously described BAC-assisted mutagenesis (Luna et al., 2004; Melancon et al.,
2005). The ΔUL11 virus was constructed by deleting most of the UL11 ORF taking care not to interrupt
the UL12 ORF that overlaps with the UL11 ORF by 87 bps. Previously, a similar UL11-null virus,
R7219, carrying a UL11 deletion of 176 bps was constructed using classical recombination experiments
(Baines and Roizman, 1992b). In comparison, the ΔUL11 virus carried an additional deletion of 18 bps.
Overall, the new ΔUL11virus confirmed previous findings with the R7219 virus, since both viruses
exhibited a significant reduction in virus replication. However, the R7219 virus exhibited a major defect
in capsid envelopment via budding through the nuclear membrane resulting in an unusual accumulation
of intra-nuclear capsids as well as a reduced number of enveloped capsids in the cytoplasm (Baines and
Roizman, 1992b). In contrast to these findings, the ΔUL11virus accumulated capsids in the cytoplasm of
infected cells that failed to acquire cytoplasmic envelopes. There was no apparent defect in nuclear
egress as evidenced by the lack of accumulation of capsids into the nucleus or incomplete nuclear
budding processes. Importantly, the ΔUL11 virus accumulated capsids in the cytoplasm of infected cells
in large aggregates surrounded by electron-dense material, which may be derived by tegument proteins.
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A similar ultrastructural phenotype was observed for the pseudorabies (PRV) UL11-null virus, with the
exception that capsid aggregates were embedded within strongly electron-dense structures of uniform
density attributed to the accumulation of capsid proteins (Kopp et al., 2003). Therefore, the HSV-1(F)
UL11 gene functions in cytoplasmic envelopment in a similar manner to that of the PRV UL11 gene.
The UL11 protein is anchored to TGN membranes through an N-terminal myristylate anchor. In
addition, the UL11 protein contains a di-Leucine and an acidic amino acid motif, which are known to be
involved in physical interactions with the UL16 protein, as well as recycling from the plasma
membranes to TGN. Deletion of either motif abrogates UL16 interaction and plasma membrane TGN
recycling (Loomis et al., 2001; Loomis, Courtney, and Wills, 2003). The ΔUL11 virus is predicted to
code for the first 32 amino acids of the UL11 protein effectively retaining the di-Leucine motif, while
deleting the entire acidic motif. In contrast, the R7219 virus is predicted to code for the first 39 amino
acids of the UL11 protein, effectively retaining the di-Leucine motif as well as three of the seven amino
acids of the acidic acid motif. Thus, it can be predicted that both UL11 peptides coded by the ΔUL11
and R7219 viruses could be myristylated and anchored to TGN membranes. However, the ΔUL11
protein could not interact with the UL16 protein since the entire acidic motif is deleted. In contrast, it is
possible that the R7219 UL11 protein may be able to interact with the UL16 protein since the di-Leucine
motif is intact and three of the 7 acidic amino acids remain with the protein. It has been reported that the
UL16 tegument protein is present on intranuclear assemblons and a structural component of mature
virions (Nalwanga et al., 1996). Therefore, these subtle differences in the UL11 amino terminal peptides
may account for the reported delay of nuclear egress for the R7219 virus, which may be caused by an
aberrant interaction of the UL11 amino terminal peptide encoded by the R7219 virus with UL16 at the
nuclear membrane.
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The ΔUL11 ultrastructural phenotype is similar to the PRV UL11-null virus, with the exception
that PRV-UL11-null virus formed capsids within a highly uniform electron dense material, which
appeared to be derived from tegument proteins. In contrast, the ΔUL11 appeared to have a diffuse
electron dense material surrounding the unenveloped capsids. The 32 amino acid UL11 peptide coded
by the UL11-null virus retains the site of myristilation at its N- terminus, and thus, could be anchored to
the TGN membranes. The PRV-UL11-null virus does not code for any UL11-derived peptide, since the
UL11 initiation codon was altered by site-directed mutagenesis(Kopp et al., 2003). Therefore, the
ΔUL11 amino terminal peptide within TGN membranes as well as in the cytoplasm may interact with
other tegument proteins preventing the more pronounced aggregation of tegument proteins produced by
the PRV UL-11-null virus.
To address potential synergistic effects between the UL11 and UL20 genes in cytoplasmic
envelopment, we constructed the ΔUL20/UL11 double-null virus. Surprisingly, the ΔUL20/UL11
double-null virus exhibited replication characteristics very similar to the UL20-null virus. Similarly, the
ultrastructural phenotype of the double-null virus was largely similar to the UL20-null virus, without
any apparent contribution by the UL11-null mutation. Additional studies in transient expression systems
revealed that UL11 and UL20/gK were transported to TGN independently of each other indicating that
they did not physically or otherwise functionally interact in either cells expressing only the UL11 and
UL20/gK genes, or in cells infected with virus. Taken together, these results suggest that the UL11
functions in cytoplasmic envelopment are totally dependent on UL20 expression. One way to interpret
this apparent dependence of UL11 on UL20 is that the UL20 protein functions in an earlier cytoplasmic
envelopment step with UL11, which is required for UL11 function. However, this prediction is contrary
to the observation that the UL11-null virions accumulate capsids with aberrant tegument-derived
structures, apparently distal to TGN-membranes. One interpretation of these results is that in the absence
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of UL20 protein there is an irreversible attachment to TGN membranes that cannot be overcome by the
UL11-null mutation. In contrast, the UL11-null mutation may allow initial binding of tegumented
capsids to membranes followed by capsid release forming the observed aggregates of capsids embedded
in tegument-like material. In this instance, the known physical interaction of UL11 with UL16 may in
part, be responsible for the observed defect in tegument protein accumulation in the cytoplasm, since in
the absence of UL11, UL16 as well as other tegument proteins that may interact with UL11 would not
bind to TGN membranes, but remain free in the cytoplasm. An alternative scenario is based on the
observation that the cellular intracytoplasmic membranes seemed to be restructured in the absence of the
PRV UL11 indicating that UL11 may play some stabilization role in Golgi-TGN membranes in infected
cells (Kopp et al., 2003). In this regard, it is possible that gK/UL20 may play a similar stabilization role
for TGN membranes and specifically at capsid budding sites. In Vero cells Golgi stacks are largely
fragmented during infection (Campadelli et al., 1993), which would argue against overall Golgi-TGN
stabilization roles for either gK or UL20. However, concurrent action of gK/UL20 and UL11 at TGN
budding sites may occur with gK/UL20 playing a dominant role over UL11.
The UL20/gK heterodimer is of paramount importance in cytoplasmic envelopment, since deletion
of either gene causes profound accumulation of cytoplasmic capsids and reduction of viral titers by more
than three logs, while viral plaques are greatly diminished in size. It is important to determine if the
UL20/gK functions precedes those of other viral glycoproteins that are known to function in cytoplasmic
virion envelopment such as gE/gI and gM. In this regard, an investigation of the phenotype of double
mutants carrying deletions in more than one gene may shed some light in the sequence of events that
control cytoplasmic envelopment.
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CHAPTER 3
HERPES SIMPLEX VIRUS TYPE-1 (HSV-1) UL16 IS REQUIRED FOR
EFFICIENT NUCLEAR EGRESS AND CYTOPLASMIC VIRION
ENVELOPMENT
Introduction
Herpes simplex virus type-1 (HSV-1) morphogenesis occurs in multiple stages within infected
cells. Initially, the virion capsid assembles within the nucleus and the virion acquires an initial envelope
by budding into the perinuclear spaces (Roizman and Sears, 2001). Subsequently, these enveloped
virions fuse with the outer nuclear lamellae leading to the accumulation of unenveloped capsids into the
cytoplasm. Within the cytoplasm, a number of additional tegument proteins attach to the capsid, and the
fully tegumented capsids bud into cytoplasmic vesicles, which most likely originate from the transGolgi network (TGN). Enveloped virions are ultimately secreted to extracellular spaces through the
utilization of cellular vesicular trafficking systems (Browne et al., 1996; Granzow et al., 2001; Harley,
Dasgupta, and Wilson, 2001; Mettenleiter, 2002; Skepper et al., 2001; Zhu et al., 1995). The process by
which the tegumented cytoplasmic capsids bud into TGN-derived vesicles is not well-understood. The
prevalent model calls for specific interactions among viral tegument proteins and the cytoplasmic
portions of membrane proteins and glycoproteins embedded within TGN membranes as key factors that
drive cytoplasmic virion envelopment. This model is supported by evidence that specific mutations
within tegument proteins and multiple membrane proteins and glycoproteins inhibit cytoplasmic
envelopment (Mettenleiter, 2004; Mettenleiter, 2006).
One pair of viral proteins, which is thought to contribute to cytoplasmic virion envelopment is
the tegument protein UL16 and the lipid membrane anchored tegument protein UL11. Specifically,
UL16 was shown to specifically interact with UL11 (Loomis, Courtney, and Wills, 2003; Vittone et al.,
2005). The UL16 ORF encodes a 373 amino acid protein (Nalwanga et al., 1996) that is associated with
intra-nuclear assemblons early in the HSV-1 life cycle. Later it is found associated with peri-nuclear
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virions and is a component of purified virions in HSV-1 and HCMV (Nalwanga et al., 1996; Ward,
Barker, and Roizman, 1996; Wing, Lee, and Huang, 1996), but not HSV-2 (Oshima et al., 1998).
Assemblons are believed to be sites at which capsid assembly and/or DNA cleavage and packaging may
occur (Ward, Ogle, and Roizman, 1996), suggesting a possible role for UL16 in these processes.
However, studies on a UL16 null virus (R7210) indicate that the UL16 protein was dispensable for
HSV-1 replication in cell culture, although the virus did replicate at titers 3 to 10 fold lower than those
of the wild type virus (Baines and Roizman, 1991).
The UL11 ORF encodes a 96 amino acid tegument protein, which is N-terminally myristylated
(MacLean, Clark, and McGeoch, 1989) and palmitylated (Loomis et al., 2001). The UL11 protein
localizes to nuclear and TGN-derived apparatus derived membranes in infected cells (Baines et al.,
1995), but only to the TGN-membranes in non-infected cells (Bowzard et al., 2000). UL11 is believed
to play a significant role in cytoplasmic envelopment as UL11 deletion mutants display a severe defect
at this step in both HSV-1 (Baines and Roizman, 1992b; Fulmer et al., 2007) and PRV (Kopp et al.,
2003). The interaction of UL11 with UL16 is dependant upon the presence of an acidic amino acid
cluster and a di-leucine motif located within the first 50 amino acids of UL11 (Loomis, Courtney, and
Wills, 2003).
The UL16 ORF is encoded on the antisense genomic strand completely embedded within UL15,
which is coded by the sense genomic strand. UL15 is a rarity among HSV-1 genes in that it is encoded
by two exons separated by an intron. UL16 is encoded within this intron. It was initially thought that
the UL15 intron could serve to down-regulate UL16 protein production by an antisense mechanism, but
this turned out not to be the case. In addition, the UL15 splicing event itself seems to have no effect on
viral growth (Baines and Roizman, 1992a). The initial studies with a UL16-null virus involved deletion
of the UL16 gene (Baines and Roizman, 1991). Due to the fact that the significance of the UL15 intron
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and UL15 splicing event is not known, for this study, we sought to delete UL16 without disrupting the
amino acid coding sequence of UL15. To achieve this, we employed a recently described marker-less
recombination system to introduce single point mutations into the HSV-1 bacterial artificial
chromosome (BAC), pYEBac102 (Tischer et al., 2006). Using this system we were able to silence the
start codon of UL16 without altering the amino acid sequence of UL15.

Materials and Methods
Cells, viruses and plasmids
African green monkey kidney (Vero) cells were obtained from the American Type Culture
Collection (Rockville, Md.). Cells were maintained in Dulbecco’s modified Eagle’s medium (GibcoBRL; Grand Island, N.Y.), supplemented with 10% fetal calf serum and antibiotics.

PCR Primer Design
Marker-less RED recombination in E. coli is accomplished mostly through a novel idea for the
targeting of mutations using specific PCR primers (Tischer et al., 2006) . The 5’ end of the first primer
contains approximately 40 bps upstream of the site to be mutated, followed by the mutant DNA
sequence(s), and followed by an additional 20 bps downstream of the target site. The 3’ end of the
forward primer anneals to pEPkan-S so that it overlaps an I-SceI site. The 5’ end of the reverse primer
was designed so that it contains the reverse complement of 40 bps downstream of the target site,
followed by the reverse complement of the target site, and then an additional 20bps upstream of the
target site. The 3’ end is designed to anneal to reverse complement sequences downstream of the
AphA1conferring Kanamycin resistance encoded by pEPkan-S. Using these primers to amplify the
AphA1 gene on pEDkan-S, results in a PCR product that contains identical sequences containing the
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desired mutation flanking both an I-SceI site and the Kanamycin resistance cassette. Primer sequences
used in this study are given in Table 3.1.

Construction of HSV-1 mutants containing deletions of the UL16 or UL11 gene (pYEBacΔUL16,
pYEBacΔUL11)
Mutagenesis of pYEbac102 DNA was accomplished in Escherichia coli using the RED
recombination machinery as described previously (Tischer et al., 2006). To create pYEBacΔUL16 BAC
maintenance and mutagenesis were performed in E. coli strain EL250 which contains a λ prophage
which encodes recombination enzymes Exo, Beta, and Gam under a heat inducible promoter (Lee et al.,
2001). EL250 cells were made electrocompetent and were transformed with pYEBac102 to produce
EL250-BAC. RED recombination was induced in the EL250-BAC cells and they were once again made
electrocompetent. EL250-BAC with RED induced was then transformed with pBAD-I-SceI, containing
an arabinose inducible I-SceI homing endonuclease cassette, and the UL16-Kan PCR product. The
transformation was plated on plates containing chloramphenicol (12.5 μg/ml), ampicillin (100 μg/ml),
and kanamycin (50 μg/ml). Colonies were screened for correct integration of the UL16-Kan PCR
product using the UL16 test primers from Table 1. Clones that were confirmed to have the correct
integration were grown from a 1:1000 dilution for 2 hours, followed by addition of .5% final
concentration of arabinose and another 1 hour of growth. Cultures were then placed in a 42OC water
bath for 30 minutes, followed by a final 1 hour of growth. 100μL of culture was plated on
chloramphenicol and ampicillin plates. After 24 hours, colonies were screened for loss of kanamycin
resistance. Kanamycin sensitive colonies were prepared and sent for sequencing to confirm the presence
of the desired mutation. Construction of pYEBacΔUL11 was described previously (Fulmer et al., 2007).
All mutations were confirmed by DNA sequencing.
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Table 3.1 Primer Design for RED Recombiniation.

Table 3.1
Primers

Primer
designat
ion
A

B

Name

Sequence1

3’ UL11Kan

5’GGGTTTTTTAAAAACGACACGCGTGCGACCGTATACAGAAATTGTTTTGGcggttgatgagag
ctttgttgtaggtggac-3’
5’AACGTCCTCATCACCGACGACGGGGAGGTCGTCTCGCTGACCGCCCACGACTagccacgt
tgtgtctcaaaatctctgatgtta-3’
5’GACCAGGCGGCGCCAGGGGCCGCCGGGGTCCCAGCTGCGCTATGCCGGGGGCGGG
GGGAGGGCaggatgacgacgataagt aggg -3’
5’GGCCCCCGCCTCTGGGGTTTGCCCTCCCCCCGCCCCCGGCATAGCGCAGCTGGGAC
CCCGGCGgcaaccaattaaccaattct gattag-3’
5’-GCACCAGCGCGGAGGAGGGC-3’

5’ UL11Kan
3’ UL16Mut
5’ UL16Mut

a

3’ UL11Rev

b

5’UL11-For

5’-ATTGTACGCCCAAGATACAACACCG-3’

c

3’ UL16Rev

5’- AATCGCCGCCTCTGTGGCATAGTTG -3’

d

5’ UL16-For

Purpose

UL11 GET
recombination

UL16 RED
recombination

Diagnostic PCR for
wt UL11 or ΔUL11Kan

Test PCR for
confirmation of
correct PCR
product integration

5’- GACGGAGTTGACAATGCGCGCG -3’

1

HSV-1 homologous regions are denoted by uppercase letters, lowercase letters signify sequences which bind to the
marker gene, point mutations in red.
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Transfection of HSV-1 BAC DNAs
Transient transfection of cells with BAC DNAs was performed with Lipofectamine 2000
(Invitrogen) and infectious virus was recovered as detailed previously (Fulmer et al., 2007; Melancon et
al., 2005). VERO cells were grown to 95% confluency in
six-well plates. Cells were transfected with BAC DNA mixed with Lipofectamine 2000 in Opti-MEM
medium as recommended by the manufacturer (Invitrogen). After 6 h of incubation at 37°C, the medium
was removed from the transfected cells, cells were washed with phosphate buffered saline, and
subsequent fresh Dulbecco’s modified Eagle’s medium with 10% fetal calf serum was added. At 72 h
post transfection, virus stocks were collected.

One-step growth kinetics and plaque morphology of YEbac102 mutants
Analysis of one-step growth kinetics was as described previously (Foster, Alvarez, and
Kousoulas, 2003; Foster, Rybachuk, and Kousoulas, 2001). Briefly, each virus at an MOI of 2 was
adsorbed to approximately 6 x 105 Vero cells at 4°C for 1 h. Thereafter, warm medium was added, and
virus was allowed to penetrate for 2 h at 37°C. Any remaining extra-cellular virus was inactivated by
low-pH treatment (0.1M glycine, pH 3.0). Cells and supernatants were harvested immediately thereafter
(0 h) or after 4, 8, 12, 24, or 36h of incubation at 37°C. Virus titers were determined by endpoint
titration of virus stocks on Vero cells.
Analysis of plaque morphology of mutant viruses was as follows. Confluent Vero cell
monolayers in 6 well plates were infected with the indicated virus. To visualize the plaques, cells were
stained with a polyclonal HRP conjugated HSV-1 antibody as directed by the manufacturer
(DakoCytomation), and as described previously (Fulmer et al., 2007; Melancon, Foster, and Kousoulas,
2004b; Melancon et al., 2005). Briefly, cells were washed with PBS to remove methylcellulose media,
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and fixed with 4°C methanol for 15 minutes. TBS containing a 1:750 dilution of the polyclonal HSV-1
antibody was added to the cells and placed on a rocker at 4°C for 1 h. Cells were washed with TBS and
developed using the VECTOR NovaRED peroxidase substrate kit as directed by the manufacturer
(VECTOR, Inc).

Electron microscopy
Cell monolayers were infected with the indicated virus at an MOI of 3. All cells were prepared
for transmission electron microscopy (TEM) examination at 24 h post infection. Infected cells were
fixed in a mixture of 2% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer,
pH 7.3. Following treatment with 1% OsO4 and dehydration in an ethanol series, the samples were
embedded in Epon-Araldyte resin and polymerized at 70°C. Thin sections were made on an MTXL
ultratome (RMC Products), stained with 5% uranyl acetate and citrate/nitrate/acetate lead, and observed
with a Zeiss 10 transmission electron microscope as described previously (Foster et al., 2004b;
Melancon, Foster, and Kousoulas, 2004b).

Results
Construction of the HSV-1 BAC pYEbacΔUL16
The complete HSV-1(F) genome has been cloned into a bacterial artificial chromosome (BAC;
pYEbac102) enabling the genetic manipulation of the HSV-1 genome in E. coli. (Tanaka et al., 2003).
Previously, we utilized the BAC-based GET homologous recombination system to construct deletions
within the gB, UL20 and gK genes in E. coli (Melancon et al., 2005). A similar strategy was utilized to
construct a HSV-1 BAC with most of the UL11 ORF deleted(Fulmer et al., 2007). A recently described
markerless RED recombination system was used to generate the pYEbac102ΔUL16 mutant. This
system allowed for the construction of a pYEbac102 mutant with a single point G to A mutation that
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silenced the ATG start codon of UL16, while leaving the amino acid sequence of the overlapping UL15
gene intact. pYEbac102ΔUL16 contains the ΔUL16 mutation and pYEbac102ΔUL11 contains the
ΔUL11 mutation (Figure 3.1).

Figure 3.1: Schematic of the strategy for the construction of mutant BACs ΔUL16 and
ΔUL11 YEbac102. (A) The top line represents the prototypic arrangement of the HSV-1
genome, with the unique long (UL) and unique short (US) regions flanked by the terminal repeat
(TR) and internal repeat (IR) regions. (B) Shown below are the expanded genomic regions of
the UL11 and UL16 ORFs. (C) PCR fragments containing the kanamycin resistance gene
cassette flanked by approximately 50 bp of viral sequences on both sides were used for targeted
GET recombination in E. coli to construct pYEbac102 mutant UL11 BACs with insertiondeletion mutations in the UL11 ORF. The approximate locations of the primers used in
amplification of each PCR fragment are also shown. For construction of the ΔUL16 mutant, a
single point mutation was introduced to silence the UL16 ORF, shown in red.
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Production of infectious virus from pYEbac102-based constructs
To generate virus stocks from the mutant pYEbac102 constructs, transient transfection of individual
BAC DNAs was performed into Vero cells (see Materials and Methods). For all transfection
experiments, virus plaques became visible 72 hours post transfection, and virus stocks were collected.

Plaque morphology and replication kinetics of HSV-1 YEbac102 mutants
As we have noted previously, construction of mutant HSV-1 viruses using the YEbac102 plasmid
allows for the rapid generation of recombinant viruses carrying desired mutations without the need for
extensive plaque purification, which is normally needed when recombinant viruses are produced via
classical homologous recombination in cell culture (Melancon et al., 2005). To assess and compare the
effect of the deletion of the UL16 and UL11 genes in the context of the same viral HSV-1(F) genomic
background on cell-to-cell spread, the plaque morphologies of the YEbac102, YEbac102ΔUL16, and
YEbacΔUL11viruses were examined in Vero cells (Fig. 3.2). As expected, the wild-type YEbac102
produced large plaques on infected cells. In contrast, the YEbac102ΔUL16 and YEbac102ΔUL11
viruses produced plaques approximately one third the size of the wild-type virus. To ensure this
phenotype was due only to the deletion of the intended gene, and not some other spurious mutation,
YEbacΔUL16 and YEbac102ΔUL11 rescued viruses were also examined. The YEbac102ΔUL16 rescue
was achieved by designing primers for the RED recombination system that simply reversed the original
mutation. The YEbac102ΔUL11 rescue was achieved by transient complementation of the mutant virus
with UL11 on Vero cells as described previously for the YEbac102ΔUL11 virus (Fulmer et al., 2007).
Rescue of the YEbac102ΔUL16 mutation produced the expected wild-type morphology, indicating that
the UL16 viral plaque phenotype was as in the case of UL11, solely due to the introduced UL16
silencing mutation (Fig. 3.2).
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Figure 3.2: Plaque morphology of mutant viruses. Plaque morphology of wild-type YEbac102 (A),
ΔUL16 (B), ΔUL11 (C), ΔUL16 rescue (D), and ΔUL11 rescue (E). Viruses were infected on VERO
cell monolayers, and plaques were visualized by immunohistochemistry 24 h.p.i.
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Figure 3.3: Viral replication kinetics. Comparison of the viral replication characteristics of
YEbac102 (♦), YEbac102ΔUL11 (■), and YEbac102ΔUL16 (▲) on Vero cells. One-step
growth kinetics of infections virus production was calculated after infection at an MOI of 2
followed by incubation at 37°C.
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To examine the effect of the various mutations on virus replication, Vero cells were infected at an MOI
of 2 with either the wild-type or each mutant virus. Virus stocks were prepared at 0, 4, 8, 12, 24, and 36
h.p.i and titrated in triplicate onto VERO cells. Viral titers of ΔUL16 and ΔUL11 were similar to each
other, with both viruses exhibiting more than a log reduction in growth when compared to the wild-type
virus, YEbac102 (Fig. 3.3).

Ultrastructural characterization of the YEbac102ΔUL16 and YEbac102ΔUL11 mutant viruses
The ultrastructural phenotypes of the Ybac102ΔUL16, and YEbac102ΔUL11 viruses relative to the
YEbac102 parental virus were investigated utilizing transmission electron microscopy at 24 h.p.i. As
expected, the YEbac102 virus exhibited no apparent defects in virion egress as exemplified by the
presence of fully enveloped virions extracellularly, as well as the presence of fully enveloped virions
intracellularly (Melancon et al., 2005)(not shown). Additionally, the YEbac102ΔUL11 virus exhibited a
phenotype similar to that described in previous experiments, notably, accumulations of largely
unenveloped capsids in the cytoplasm associated with a more electron dense material presumed to be
composed of tegument proteins (Fulmer et al., 2007)(not shown). In contrast, the YEbac102ΔUL16
virus exhibited a phenotype suggesting a block in nuclear egress. Uncommon accumulation of
nucleocapsids were found in the nucleus, while a low number of cytoplasmic virions and extracellular
fully enveloped virions were also noted (Fig. 3.4).

Discussion
HSV-1 cytoplasmic virion envelopment is thought to be mediated by complex interactions among
tegument proteins and viral glycoproteins embedded in the TGN membranes. A number of viral
glycoproteins have been shown to either interact with tegument proteins or otherwise affect cytoplasmic
envelopment. Likewise, specific tegument proteins have been implicated in cytoplasmic virion
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Figure 3.4: Ultrastructural characterization of ΔUL16. Confluent cell monolayers were infected
with the YEbac102ΔUL16 virus at an MOI of 2, incubated for 24 hrs at 37°C, and prepared for
transmission electron microscopy. Typical intranuclear accumulation of capsids (black arrow). Also
indicated are unenveloped cytoplasmic virions (white arrow).
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envelopment, presumably because they either directly or indirectly affect proper interactions with the
cytoplasmic domains of viral membrane proteins and glycoproteins embedded within TGN-derived
vesicles. Of particular interest to this study was the interaction between the membrane associated
tegument protein UL11 and the virion associated tegument protein UL16. In this manuscript we created
a HSV-1 mutant that contained a single point mutation to silence the UL16 start codon. We compared
this virus, ΔUL16, with our previously constructed UL11-null virus, ΔUL11. We found that: 1) ΔUL16
exhibits similar plaque morphology to that of ΔUL11; 2) However, unlike ΔUL11, ΔUL16 exhibited
predominantly a nuclear egress defect; 3) UL16 may also have a defect in cytoplasmic envelopment,
because examination of multiple electron micrographs suggested the presence of unenveloped capsids in
the cytoplasm at time points, where wild-type infections did not contain any unenveloped capsids in the
cytoplasm. These results led to the conclusion that UL16 functions primarily in nuclear virion assembly
and egress, while secondarily may also function in cytoplasmic virion envelopment. To assess the role
of UL16 in virion morphogenesis and egress, the YEbac102ΔUL16 virus was constructed using a
recently described RED markerless recombination system (Tischer et al., 2006). This allowed for the
construction of ΔUL16 without changing the amino acid coding sequence of the gene found on the
complementary strand, UL15. UL15 is involved in HSV-1 viral genome cleavage and packaging into
mature virions (Abbotts et al., 2000; Beard, Taus, and Baines, 2002). UL16 is encoded on the
complementary strand to UL15, located completely within the single intron of UL15. The role of this
intron is not well understood. Previous studies have shown that the UL15 intron did not serve to
downregulate UL16 expression by an antisense mechanism, nor is the splicing event itself necessary for
proper UL15 function (Baines and Roizman, 1992a). Because the roles of the UL15 splicing event and
its intron are not well understood, we sought to create a UL16-null virus that did not alter the amino acid
sequence of UL15. This was accomplished by introducing a single point mutation into the UL16 ATG
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to change it to ATA. Introduction of this mutation effectively silenced UL16 production, while only
altering the UL15 coding sequence from GCC to GCT, both of which code for alanine. ΔUL16
exhibited a similar defect in growth kinetics to that of a previously described UL16-null virus, R710
(Baines and Roizman, 1991).
However, ΔUL16 showed a markedly different ultrastructural phenotype than that of R7210 (Baines and
Roizman, 1991)(not shown). Specifically, ΔUL16 virions exhibited predominantly a nuclear defect
resulting in accumulation of virions within the nucleus, as well as a slight accumulation of unenveloped
virions in the cytoplasm. This observation seems to suggest two roles for UL16, one in nuclear capsid
assembly/egress, and a second role in cytoplasmic envelopment. The differences in the ultrastructural
phenotypes between ΔUL16 and R7210 may be attributed to a possible role for the UL15 intron
sequences deleted in R7210, but remaining in ΔUL16.
The UL11 protein is anchored to TGN membranes through an N-terminal myristylate anchor. In
addition, the UL11 protein contains a di-Leucine and an acidic amino acid motif, which are known to be
involved in physical interactions with the UL16 protein, as well as recycling from the plasma
membranes to TGN. Deletion of either motif abrogates UL16 interaction and plasma membrane TGN
recycling (Loomis et al., 2001; Loomis, Courtney, and Wills, 2003). Interaction of this TGN membrane
associated UL11 and the capsid associated UL16 provides a potential pathway for interactions between
mature cytoplasmic virions and glycoprotein bearing TGN-vesicles for final cytoplasmic envelopment
and egress from infected cells. The relatively minor accumulation of cytoplasmic tegumented capsids in
ΔUL16 infected cells indicates that cytoplasmic capsids, which escaped the nuclear egress block, may
not be able to efficiently envelope by budding into TGN membranes, in agreement with the known
interactions between UL11 and UL16. However, the presence of fully enveloped virions suggests that
this interaction does not play a major role in cytoplasmic virion envelopment. HSV proteins appear to
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be multifunctional contain separable domains that possess different functions in the life cycle of the
virus. Therefore, generation of a cadre of UL16 mutations and truncations may be able to segregate
domains of UL16 that function in nuclear egress from those that function in cytoplasmic virion
envelopment.
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CHAPTER 4
CONCLUDING REMARKS
Summary
Herpes simplex virus type-1 (HSV-1) morphogenesis occurs in multiple stages within
infected cells. Initially, the virion capsid assembles within the nucleus and the virion acquires an
initial envelope by budding into the perinuclear spaces (Roizman and Sears, 2001).
Subsequently, these enveloped virions fuse with the outer nuclear lamellae leading to the
accumulation of unenveloped capsids into the cytoplasm. Within the cytoplasm, a number of
additional tegument proteins attach to the capsid and the fully tegumented capsids bud into
cytoplasmic vesicles, which mostly likely originate from the trans-Golgi network (TGN).
Enveloped virions are ultimately secreted to extracellular spaces through the utilization of
cellular vesicular trafficking systems (Browne et al., 1996; Granzow et al., 2001; Harley,
Dasgupta, and Wilson, 2001; Mettenleiter, 2002; Skepper et al., 2001; Zhu et al., 1995). The
process by which the tegumented cytoplasmic capsids bud into TGN-derived vesicles is not wellunderstood. The prevalent model calls for specific interactions among viral tegument proteins
and membrane proteins and glycoproteins embedded within TGN membranes as key factors that
drive cytoplasmic virion envelopment. This model is supported by evidence that specific
mutations within tegument proteins and multiple membrane proteins and glycoproteins inhibit
cytoplasmic envelopment (Mettenleiter, 2004; Mettenleiter, 2006).
To further investigate the roles of tegument proteins in cytoplasmic virion envelopment, we
constructed deletion mutants of UL11 (ΔUL11), UL20 (ΔUL20), both UL11 and UL20 (ΔUL11ΔUL20),
and UL16 (ΔUL16). The UL11 ORF encodes a 96 amino acid tegument protein, which is N-terminally
myristylated (MacLean, Clark, and McGeoch, 1989) and palmitylated (Loomis et al., 2001). The UL11
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protein localizes to nuclear and TGN-derived apparatus derived membranes in infected cells (Baines et
al., 1995), but only to the TGN-membranes in non-infected cells (Bowzard et al., 2000). UL11 is
believed to play a significant role in cytoplasmic envelopment as UL11 deletion mutants display a
severe defect at this step in both HSV-1 (Baines and Roizman, 1992b; Fulmer et al., 2007) and PRV
(Kopp et al., 2003). The interaction of UL11 with UL16 is dependant upon the presence of an acidic
amino acid cluster and a di-leucine motif located within the first 50 amino acids of UL11 (Loomis,
Courtney, and Wills, 2003). The interaction between UL11 on TGN-membranes and the capsid
associated UL16 presents a possible pathway for the recruitment of cytoplasmic capsids to TGN-derived
membranes for final envelopment. The UL20 ORF encodes a multipass transmembrane proteins of 222
amino acids and is conserved in all alphaherpesviruses (Debroy, Pederson, and Person, 1985; MacLean
et al., 1991; Ramaswamy and Holland, 1992). UL20p localizes to TGN membranes after endocytosis
from cell surfaces (Foster et al., 2004b). UL20p is essential for cytoplasmic virion morphogenesis, since
mutant viruses lacking UL20p accumulate capsids within the cytoplasm that are unable to acquire
envelopes by budding into TGN-associated membranes (Dietz et al., 2000; Foster, Alvarez, and
Kousoulas, 2003; Foster et al., 2004b; Fuchs et al., 1997; Melancon, Foster, and Kousoulas, 2004b).
Furthermore, UL20p is essential for virus-induced cell fusion caused by either gB or gK syncytial
mutations, and it is necessary for gK cell-surface expression. Recently, our laboratory has shown that gK
and UL20 interact and that this interaction is essential for their co-transport and membrane fusion and
virion morphogenesis functions (Foster et al., 2004d; Melancon et al., 2005). The UL16 ORF encodes a
373 amino acid protein (Nalwanga et al., 1996) that is associated with intra-nuclear assemblons early in
the HSV-1 life cycle and is later found associated with peri-nuclear virions and is a component of
purified virions in HSV-1 and HCMV(Nalwanga et al., 1996; Ward, Barker, and Roizman, 1996; Wing,
Lee, and Huang, 1996), but not HSV-2 (Oshima et al., 1998). Assemblons are believed to be sites at
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which capsid assembly and/or DNA cleavage and packaging may occur (Ward, Ogle, and Roizman,
1996), suggesting a possible role for UL16 in these processes.
Chapter 2 presents evidence that UL11 is involved in cytoplasmic virion envelopment. The
ΔUL11 virus exhibits large amounts of unenveloped capsids in the cytoplasm of infected cells. To
examine if UL11 worked synergistically with UL20 in cytoplasmic envelopment, the ΔUL11ΔUL20
virus containing deletions of both UL11 and UL20 was examined. The phenotype of the double null
virus most closely resembled that of the UL20 single null virus (ΔUL20) in all areas: plaque phenotype,
growth kinetics, and ultrastructural characteristics. Similar to the UL20/gK heterodimer, UL11 localizes
to TGN-derived vesicles during virus infection (Foster et al., 2004b; Loomis, Courtney, and Wills, 2003;
Vittone et al., 2005). To asses whether UL11 has any affect on UL20/gK localization, confocal
experiments to determine the localization of UL11, UL20 and gK, revealing that UL11 transport was
completely independent of UL20/gK. Taken together these results indicate that UL11 acts at a step in
cytoplasmic envelopment downstream of UL20, and UL20 is required for proper UL11 function.
However, UL11 is not dependent upon the UL20/gK heterodimer for its transport.
Chapter 3 presents evidence that UL16 serves a two-fold purpose in HSV-1 virion
morphogenesis and egress from infected cells. To assess the role of UL16 in virion morphogenesis and
egress, the YEbac102ΔUL16 virus was constructed using a recently described RED markerless
recombination system (Tischer et al., 2006). This allowed for the construction of ΔUL16 without
changing the amino acid coding sequence of the gene found on the complementary strand, UL15. UL15
is involved in HSV-1 viral genome cleavage and packaging into mature virions (Abbotts et al., 2000;
Beard, Taus, and Baines, 2002). UL16 is encoded on the complementary strand to UL15, located
completely within the single intron of UL15. The role of this intron is not well understood, past studies
have shown that it does not serve to downregulate UL16 production by an antisense mechanism, nor is
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the splicing event itself necessary for proper UL15 function (Baines and Roizman, 1992a). Because the
role of the UL15 splicing event and its intron are not well understood, we sought to create a UL16-null
virus that did not alter the amino acid sequence of UL15. This was accomplished by introducing a
single point mutation into the UL16 ATG to change it to ATA. This effectively silenced UL16
production while altering the UL15 coding sequence from GCC to GCT, both of which code for
alanine(Baines and Roizman, 1991). ΔUL16 exhibited a plaque phenotype and growth kinetics similar
to that of the ΔUL11 virus. However, the viruses differed slightly with respect to their ultrastructural
characteristics. While both ΔUL16 and ΔUL11 exhibited a cytoplasmic envelopment defect, the defect
seen in ΔUL16 was much less severe than that of ΔUL11. Instead, ΔUL16 showed a large accumulation
of intranuclear capsids not seen in the ΔUL11 virus. This result indicates a two-fold role for UL16 in
virion morphogenesis and egress: 1) The nuclear accumulation of capsids seems to suggest that the first
and most important role of UL16 is in intranuclear capsid assembly/egress. 2) The cytoplasmic
accumulation of capsids suggests that UL16 also plays a role in cytoplasmic envelopment. These results
indicate a possible pathway for the juxtaposition of cytoplasmic capsids with TGN-derived vesicles for
final cytoplasmic envelopment.
In conclusion, this dissertation has capitalized on the recent availability of herpes simplex virus
type-1 BAC mutagenesis protocols to quickly and precisely make targeted mutations to any gene of
HSV-1. This work has led to a greater understanding of how HSV-1 undergoes cytoplasmic
envelopment and egress from infected cells.

Current and future research
The work presented in Chapter 3 leaves open the question of whether or not UL11 and UL16 act
synergistically in HSV-1 cytoplasmic envelopment. Our original hypothesis was that UL16 functioned
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in cytoplasmic events of the lifecycle based on a previous publication with a partially deleted U16 virus,
which was reported to exhibit replication defects due to the accumulation of unenveloped capsids in the
cytoplasm (ref). Based on our previous work comparing the relative contributions of UL20 and UL11
genes to cytoplasmic virion envelopment (ref), we constructed a double-null UL16/UL11 virus and
begun to characterize its replication and phenotypic properties. This work is currently in progress. The
finding that the DUL16 virus constructed with the pYEBac102 plasmid accumulated capsids within the
nucleus, apparently, unable to properly egress from the nucleus to the cytoplasm, does not allow an
ordering of the UL11 and U16 functions with respect to the potential roles of these proteins in
cytoplasmic virion envelopment, by a simple comparison of the replication and other characteristics of
the single mutants versus that of the double-null mutant virus. It is anticipated that the double-null virus
will possess the defects of the individual null mutations exhibiting approximately two logs of inhibition
of virus replication versus one log inhibition of infectious virus production by each of the null mutants.
Based on the observation that a number of HSV proteins and glycoproteins are multifunctional, it
can be predicted that potential roles of UL16 in virion assembly within the nucleus and in cytoplasmic
tegumentation and concomitant cytoplasmic virion assembly may be discerned through the investigation
of UL16 mutants that can affect one, but not necessarily the other function. An example of this
experimental approach is the delineation of functional domains of the UL20 protein (UL20p) by alaninescanning mutations, single amino acid mutations and truncations (refs), which allowed for the
segregation of UL20p domains that functioned in virion assembly from those that functioned in
intracellular transport of UL20p and its interacting partner gK (ref). In this regard, a collection of UL16
mutants with different mutations can be quickly tested in conjunction with the U16-null virus using
complementation analysis to segregate functional domains of UL16 protein.
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The ultimate goal of these studies was to begin dissecting the order of molecular events that are
responsible for intracellular virion envelopment. The most current and prevalent hypothesis is that
cytoplasmic nucleocapsids mature by the addition of a limited number of tegument proteins in the
cytoplasm, while another set of tegument proteins bind independently of the virion capsid to the
cytoplasmic portions of the membrane bound proteins and glycoproteins (ref Metenleiter).
Subsequently, tegument-tegument and tegument-membrane protein interactions drive the budding of
cytoplasmic capsids into the TGN derived vesicles. The molecular genetics approach used in these
investigations revealed valuable information about the sequence of cytoplasmic virion maturation
events that require the UL11 and UL20 functions suggesting that UL20 functions preceded those of
UL11. Construction of the UL16-null mutant virus revealed an unexpected role of UL16 in nuclear
egress of virions. In this regard, the genetic approach followed here provides one pathway for mining
the necessary information required for understanding intracellular virion assembly. Additional
experimental approaches need to be pursued including proteomic characterization of the components of
fully and partially assembled virions. Furthermore, reconstitution of intracellular cytoplasmic
envelopment using cellular extracts may become possible in the future in which individual mutant virion
particles can be tested for their ability to acquire envelopes by budding into TGN-derived vesicles.
Ultimately, complete knowledge of virion assembly may enable future researchers to build “custom”
viruses as tailored “nanomachines” that could deliver specific payloads and/or perform specific tasks.
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APPENDIX
ADDITIONAL WORK
Disclaimer
The work presented in this appendix was begun in our lab by a previous student, Jeff
Melancon. Jeff left the lab before this work could be completed, so I finished the project. This
work has not been presented before, either in Jeff’s dissertation, or in a peer-reviewed
publication. However, as I was not the sole party responsible for the body of the work, I did not
feel it warranted a separate chapter and instead it is presented here. The work presented in this
appendix highlights my contributions to the project.

Introduction
Herpes simplex viruses (HSV) specify at least eleven virus-specified glycoproteins, as
well as several non-glycosylated membrane associated proteins, most of which play important
roles in multiple membrane fusion events during virus entry and intracellular virion
morphogenesis and egress (Roizman and Sears, 1996; Spear, 1993a; Spear, 1993b; Spear,
Eisenberg, and Cohen, 2000). Spread of infectious virus occurs either by release of virions to
extracellular spaces or through virus-induced cell-to-cell fusion. In vivo, the latter mechanism
allows for virus spread without exposing virions to extracellular spaces containing neutralizing
antibodies. Mutations that cause extensive virus-induced cell fusion predominantly arise in four
genes of the HSV genome: the UL20 gene (Baines et al., 1991; MacLean et al., 1991), the UL24
gene (Jacobson et al., 1998; Sanders, Wilkie, and Davison, 1982), the UL27 gene encoding
glycoprotein B (gB) (Bzik et al., 1984; Pellett et al., 1985), and the UL53 gene coding for
glycoprotein K (gK) (Bond and Person, 1984; Debroy, Pederson, and Person, 1985; Hutchinson
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et al., 1992b; Pogue-Geile et al., 1984; Ryechan et al., 1979). Of these four membrane associated
proteins, only UL20 and gK are absolutely essential for the intracellular transport of virions to
extracellular spaces in all cell types (Baines et al., 1991; Foster and Kousoulas, 1999; Fuchs et
al., 1997; Hutchinson and Johnson, 1995; Jayachandra, Baghian, and Kousoulas, 1997). Virusinduced cell fusion requires the coordinate action of multiple viral glycoproteins including gD,
gH, gL, gB, gM, gK, as well as UL20p. This conclusion is supported by the fact that gB syncytial
mutations do not cause virus-induced cell fusion in the absence of either gH, gM, gK, or UL20.
Similarly, syncytial mutations in gK do not cause virus-induced cell fusion in the absence of gB,
or gH.
The most prevalent model of morphogenesis and egress of infectious herpes virions is
thought to involve sequential de-envelopment and re-envelopment steps in transit to extracellular
spaces: a) primary envelopment by budding of capsids assembled in the nuclei through the inner
nuclear leaflet leading to the production of enveloped virions within perinuclear spaces; b) deenvelopment by fusion of viral envelopes with the outer nuclear leaflet leading to the
accumulation of unenveloped capsids in the cytoplasm; c) assembly of sets of tegument proteins
on the cytoplasmic capsids, as well as potentially on vesicle sites to be used for cytoplasmic
envelopment; d) re-envelopment of cytoplasmic tegumented capsids into TGN-derived vesicles.
This final event in cytoplasmic virion envelopment is thought to be largely mediated by
interactions between tegument proteins and cytoplasmic portions of viral glycoproteins
embedded within the TGN-derived membranes. Cytoplasmically enveloped viruses are thought
to be transported to extracellular spaces within Golgi or TGN-derived vesicles (reviewed in:
(Johnson and Huber, 2002; Mettenleiter, 2002; Tomishima, Smith, and Enquist, 2001).
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The UL20 gene encodes a 222 amino acid non-glycosylated transmembrane protein that is
conserved by all alphaherpesviruses. The UL20p is a structural component of extracellular
enveloped virions and it is expressed in infected cells assuming a predominantly perinuclear and
cytoplasmic distribution (Ward et al., 1994). An initial report indicated that partial deletion of the
UL20 gene resulted in perinuclear accumulation of capsids indicating that the UL20 gene
functioned, most likely, in the de-envelopment of enveloped virions found within perinuclear
spaces (Baines et al., 1991). However, we showed previously that a precise deletion of the UL20
gene revealed that the UL20 gene strictly functioned in cytoplasmic envelopment of capsids
(Foster et al., 2004a). In addition, syncytial mutations in either gB or gK failed to cause fusion in
the absence of the UL20 gene, suggesting that the UL20 protein was essential for virus-induced
cell fusion (Foster et al., 2004a). Furthermore, we showed that UL20 is required for cell-surface
expression of gK and TGN localization, suggesting a functional interdependence between gK and
UL20 for virus egress and cell-to-cell fusion (Dietz et al., 2000; Foster, Alvarez, and Kousoulas,
2003). Recently, we delineated via site-directed mutagenesis the functional domains of UL20p
involved in infectious virus production and virus-induced cell fusion. Importantly, we showed
that both amino and carboxyl terminal portions of UL20p, which are predicted to lie within the
cytoplasmic side of cellular membranes, function both in cytoplasmic virion envelopment and
virus-induced cell fusion.
In this manuscript, we extend our previous findings by examining the effect previous as
well as new mutations within UL20p in intracellular transport, cell surface expression and TGN
localization of UL20 and gK. Our findings show that the amino and carboxyl termini of UL20p
contain distinct domains that function in infectious virion production and intracellular transport
and suggest that putative phosphorylation sites in the amino terminus of UL20p play important
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roles in infectious virus production and virus-induced cell fusion, but not intracellular transport
of UL20p and gK.

Materials and Methods
Cells and viruses
African green monkey kidney (Vero) cells were obtained from ATCC (Rockville, MD).
The Vero-based UL20 complementing cell line, G5, was a gift of Dr. P. Desai, (John Hopkins
Medical Center) (Desai et al., 1993). Cells were maintained as previously described (Desai et al.,
1993; Foster, Alvarez, and Kousoulas, 2003; Foster and Kousoulas, 1999). The parental wildtype strain used in this study HSV-1 (KOS) was originally obtained from P. A. Schaffer (Harvard
Medical School). Δ20DIV5, Δ20gBsyn3 and Δ20gKsyn1DIV5 viruses were as described
previously (Foster et al., 2004a). Virus stocks were grown on the UL20 complementing cell line
Fd20-1, the construction of which was described previously (Melancon, Foster, and Kousoulas,
2004a). In this paper, for simplification purposes, the Δ20DIV5 virus is referred to as Δ20 virus
and the Δ20syngK1DIV5 virus is referred to as Δ20gKsyn1 virus (Melancon, Foster, and
Kousoulas, 2004a).

Plasmids
pCR2.1-UL20, which was used as the parental vector for UL20 mutagenesis, was generated
by cloning a 773bp DNA fragment containing the UL20 gene, obtained by PCR amplification of
HSV-1(KOS) viral DNA, into pCR2.1/TOPO (Invitrogen) as described in detail previously
(Melancon, Foster, and Kousoulas, 2004a). The generation of UL20 cluster to alanine mutants
CL38, Cl49, CL153, and CL209, the single point mutant Y49A, and truncation mutants, 204t,
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211t, 216t were reported previously (Melancon, Foster, and Kousoulas, 2004a). A set of new
UL20 mutants generated for this study included, a UL20 mutant containing both the CL38 and
CL49 mutations (CL38—CL49), the alanine cluster UL20 mutant CL61, and the single point
mutants Y38A, and the UL20 mutant Y-Y containing both the Y38A and Y49A mutations. The
additional single point UL20 mutants as well as the double mutants were generated by spliceoverlap extension (SOE) PCR (Aiyar, Xiang, and Leis, 1996) as described previously (Melancon,
Foster, and Kousoulas, 2004a) . CL2 and CL61 mutants were generated using the GeneTailor™
Site-Directed Mutagenesis Kit as directed by the manufacturer (Invitrogen), and as described
previously for the other CL mutants (Melancon, Foster, and Kousoulas, 2004a).

UL20 complementation assay for infectious virion production
Confluent Vero monolayers in six well plates were transfected with 2 μg of wild-type or
mutant UL20 plasmid with Lipofectamine 2000 as described by the manufacturer (Invitrogen).
Six hours post-transfection, the monolayers were infected with a UL20-null virus at an MOI of 1.
Infections were placed on a rocker for 1 hour at 4°C, and then transferred to 37°C for 2 hours.
Residual virus was inactivated using an acid wash (PBS containing .5M glycine, pH3) for 2 min,
and monolayers were subsequently washed 3 times with DMEM to restore the pH to a normal
level. Infections were incubated at 37°C for 24 hours. After repeated freeze/thaw cycles, virus
stocks were titered in triplicate on Fd20-1 cells, which effectively complement the UL20-null
defect (Melancon, Foster, and Kousoulas, 2004a). The complementation ratio for each mutant
was calculated with the formula (virus titer of mutant / virus titer of positive control).
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UL20 complementation assay for virus-induced cell-to-cell fusion
Confluent Vero monolayers in six-well plates were transfected with 2 μg of wild-type or
mutant UL20 plasmid with Lipofectamine 2000 as described by the manufacturer (Invitrogen).
18 hours post transfection, the monolayers were infected at an MOI of 0.1 with either
Δ20gKsyn1 or Δ20gBsyn3 viruses. Infections were placed on a rocker at room temperature for 1
hour, then transferred to 37°C for 30 minutes. Cells were overlaid with DMEM containing 1%
methylcellulose. 24 hours post-infection, cell fusion was determined by visualization of syncitia
formation by light microscopy. Cells were stained with a polyclonal HRP conjugated HSV-1
antibody as directed by the manufacturer (DakoCytomation). Briefly, cells were washed with
PBS to remove methylcellulose media, and fixed with 4°C methanol for 15 minutes. TBS
containing a 1:750 dilution of the polyclonal HSV-1 antibody was added to the cells and placed
on a rocker at 4°C for 1 h. Cells were washed with TBS and developed using the VECTOR
NovaRED peroxidase substrate kit as directed by the manufacturer (VECTOR , Inc).

Results
Mutagenesis of HSV-1 UL20
Previously, we reported on the construction and characterization of a panel of 31 mutations
within the UL20 gene (Melancon, Foster, and Kousoulas, 2004a). These mutations included: 1)
cluster-to-alanine mutants in which a cluster of proximal amino acids were changed to alanine
residues; 2) single amino acid replacement mutants within alanine cluster regions; 3) carboxyl
terminal truncations of UL20p. Two additional double mutants where constructed for the present
study. UL20 mutant CL38—CL49 combined the two cluster mutations targeting the two putative
phosphorylation sites in the amino terminus of UL20p. Similarly, the Y38A—Y49A double
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mutant combined the two specific tyrosine modifications without altering adjacent amino acids.
In addition, UL20 mutants CL2, CL61, Y38A, and Y117A, which were not reported previously,
were included in these investigations. All UL20 mutants were tested for their ability to
complement UL20-null infectious virus production as well as either gB or gK-mediated virusinduced cell fusion. The mutated amino acids for each type of mutation included in this study are
shown in Table 1. The carboxyl terminal truncations are identified with the number of the last
remaining amino acid (i.e. 204t retains UL20p amino acids 1-204). The location of each mutation
with respect to the predicted and experimentally confirmed topology of UL20p (Melancon,
Foster, and Kousoulas, 2004a) is shown in Figure A.1.

Complementation assay for infectious virus production.
It was previously shown that deletion of the HSV-1 UL20 and the PRV UL20 genes
resulted in up to two logs reduction in infectious virus production relative to their parental wild
type strains (Baines et al., 1991; Foster et al., 2004a; Fuchs et al., 1997). The cadre of single or
double UL20 mutants and UL20p truncations were tested for their ability to complement the
HSV-1(KOS) UL20-null virus. Complementation experiments involved transfection of Vero
cells with plasmids encoding wild-type or mutant UL20 genes, followed by infection with the
UL20-null virus as reported previously (Foster et al., 2004a) and described in Materials and
Methods. A complementation ratio was calculated for each mutant UL20 plasmid as a percent
ratio to complementation levels provided by the wild-type UL20 gene. The UL20 wild-type gene
effectively complemented UL20-null virus infectious virus production, while most of the UL20
mutants failed to complement the UL20-null virus with the exception of the CL2 and Y117A
mutants (Figure A.2).
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Figure A.2: Complementation by UL20 mutants. Ratios of complementation for various
UL20 mutants. Vero cells were transfected with the indicated mutant then infected with the
ΔUL20 virus.
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Complementation for virus-induced cell-to-cell fusion
We previously showed that syncytial mutations in either gB or gK failed to cause virusinduced cell fusion in the absence of the UL20 gene (Foster et al., 2004a). Furthermore, a panel
of 31 different UL20 mutants revealed that UL20 domains that functioned in infectious virus
production segregated from those that functioned in virus-induced cell fusion (Melancon, Foster,
and Kousoulas, 2004a). The panel of UL20 mutants shown in Table 1 containing additional
UL20 mutants was tested for the ability to complement UL20-null viruses containing syncytial
mutations in either gB (syn3) or gK (syn1) for virus-induced cell fusion as described previously
(Melancon, Foster, and Kousoulas, 2004a). Briefly, confluent Vero monolayers were transfected
with plasmids encoding either wild type or mutant UL20p, and subsequently infected with either
Δ20gKsyn1 or Δ20gBsyn3 viruses. Viral plaques appearing as larger plaques in a background of
uniformly small UL20-null viral plaques were stained with anti-HSV-1 polyclonal antibody as
described in Materials and Methods (Figure A.3). In this complementation assay, 20-40% of all
viral plaques appeared considerably larger than the uniformly small UL20-null plaques (not
shown). The CL2 UL20 mutant (Figure A. 3) and Y117A (not shown) complemented effectively
both gB and gK-mediated virus-induced cell fusion producing rescued viral plaques similar in
size to those produced by the wild-type UL20 gene. The CL49 and Y49A mutations partially
complemented virus-induced cell fusion caused by syncytial mutations in either gB or gK, as
evidenced by the production of visibly larger than the UL20-null viral plaques; however, these
plaques were substantially smaller than those produced by complementation with the wild-type
UL20 gene. For comparative purposes, previously, we showed that the 204t and 211t UL20
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truncations failed to complement virus induced cell fusion, while the 216t truncation efficiently
complemented virus-induced cell fusion (Melancon, Foster, and Kousoulas, 2004a).
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Figure A.3: UL20 mutant complementation for fusion. Vero cells were transfected with the
indicated mutant and then infected with either ΔUL20gBsyn or ΔUL20gKsyn virus.
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